Publications:

PROF. M. L. B. Bhatt

1. Mali HR, Bhatt MLB, Srivastava M. Advanced carcinoma cervix- A comparative analysis of 3Fc/week versus 5Fc/week Radiotherapy. Indian Journal of Radiology and Imaging. 5 (4): 207-210, 1995.
2. Mali HR, Bhatt MLB, Natu SM. Effect of Radiotherapy on serum mucoprotein levels in carcinoma cervix: A preliminary report. Indian Journal of Radiology and Imaging 5 (4): 215-218, 1995.
3. Mali HR, Bhatt MLB, Gupta JP, Singh MP. Serum Sialic Acid: Possible role as a biomarker in Head and Neck cancer during Radiotherapy. Journal of Radiotherapy and Oncology X (1): 44- 46, 1995.
4. Mali HR, Bhatt MLB, Singh MP, Natu SM, Gupta JP. Effect of Radiotherapy on Serum Sialic Acid Level in Carcinoma Cervix. Indian Journal of Clinical Biochemistry 11 (1): 56-58, 1996.
5. Mali HR, Chandrawati, Natu SM, Bhatt MLB. Changes in Serum Glycoprotein Levels in Malignancy of Larynx and Pharynx due to Radiotherapy: A Preliminary Study. Indian Journal of Radiology and Imaging 7 (2): 109-112, 1996.
6. Bhatt MLB, Mali HR, Srivastava M, Natu SM, and Kumar S, Serum mucoprotein levels: a possible biomarker for carcinoma of the oral cavity treated by radiotherapy. Journal of Clinical Radiotherapy and Oncology. 11 (1): 33-35; 1996.
7. Mali HR, Siddiqui SA, Garg M, Bhatt MLB, Singh RK. Serum zinc level: A possible biomarker in malignant diseases undergoing radiotherapy. Journal of Clinical Radiotherapy and Oncology 1- 2: 61- 64, 1997.
8. Mali HR, Siddiqui SA, Garg M, Singh RK, Bhatt MLB. Changes in Serum Copper Levels in patients with malignant diseases undergoing Radiotherapy. Indian Journal of Clinical Biochemistry 13 (1): 36-40, 1998.
9. Mali HR, Gupta R, Srivastava M, Siddiqui SA, Bhatt MLB. Synchronous chemo-irradiation using cisplatin as a cyto-toxic agent in loco-regionally advanced head and neck cancer. Indian Journal of Clinical Radiotherapy and Oncology 14 (1): 135-140, 1998.
10. Bhatt MLB, Mohanti B.K, Kumar L, Chawla S, Sharma DN, Rath G.K. Palliative Treatment of Advanced Non-small Cell Lung Cancer with weekly fraction Radiotherapy. Indian Journal of Cancer 37 (4): 148-152, 2000.
11. H. Bilal, S. A. Siddiqui and Bhatt M.L. Dosimetry of blocked field-A comparative study. Journal of Medical Physics 25 (3): 167-168, 2000.
12. Mali HR, Bhatt MLB,Natu SM, Bhatia N. Effect of Radiotherapy on Serum Mucoprotein Level in Carcinoma Larynx and Pharynx. Indian Journal of Otolaryngology and Head and Neck Surgery 53 (1): 14-15, 2001.
13. Kumar R, Dwivedi JN, Sahni K, Siddiqui SA, Bhatt MLB. Evaluation of high dose intermittent synchronous Cisplatin with Radiotherapy in advanced Head and Neck Cancer. Journal of Clinical Radiotherapy and Oncology 1 (1-2): 19-24, 2001.
14. Chana RS, Mubashir M, Bhatt MLB,Varshney S, Maheshwari V. Rectal Carcinoma in a 12-years old boy. Journal of Indian Association of Pediatric Surgeons 6 (4): 152-154, 2001.
15. Kunwar S, Saxena K, Bhatt MLB, Khan T. Color flow and Doppler velocimetry indices in benign and malignant pelvic tumors. Journal of Obstetrics and Gynecology of India 52 (4): 73-75, 2002.
16. Gogi D, Bhatt MLB, Sherwani RK. Radiotherapy in combination with exenteration: A treatment modality for fungating choroidal melanoma. Journal of Clinical Radiotherapy and Oncology 2 (3): 43- 45, 2002.
17. Asif R, Chandra K, Chopra V, Bhatt MLB. Concurrent cisplatin and radiotherapy in advanced head and neck cancer. Indian Journal of Otolaryngology and Head and Neck Surgery 55 (2): 94-96, 2003.
18. Kumar A, Bhatt MLB, Singhal S. Prevalence of intestinal parasites in cancer patients. Indian Medical Gazette CXXXVII (3): 75-76, 2003.
19. Halberg F, Cornélissen G, Wang Z, Wan C, Ulmer W, Katinas G, Singh R, Singh RK, Singh RK, Gupta BD, Singh RB, Kumar A, Kanabrocki E, Robert B. Sothern, Rao G, BhattMLB et al. Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutraceuticals and beyond. Journal of Experimental Therapeutics and Oncology 3: 223- 260, 2003.
20. Ahmad Z., Gulati R., Siddiqui S.A., BhattMLB, Sharma D.K. Pulmonary function test (PFT) status in head and neck malignancy. Indian Journal of Bio research 50 (1): 173-175, 2003.
21. Rastogi M, Srivastava M, Srivastava AN, Bhatt MLB, Srivastava K. Chondroblastoma of maxilla- A case report. Oral Oncology Extra 41: 159-161, 2005.
22. Rastogi M, Srivastava K, Srivastava M, Chufal KS, BhattMLB, Srivastava AN. Multiple skin metastases in forearm from base tongue carcinoma- A case report. Oral Oncology EXTRA 41: 188-190, 2005.
23. Rastogi M, Srivastava M, Bhatt MLB, Srivastava K, Bhatia N. Laryngeal carcinoma in 13 years old child- A case report. Oral Oncology EXTRA 41: 207-210, 2005.
24. Rastogi M, Srivastava M, Kundan S, Chufal, Pant MC, Srivastava K and Bhatt MLB. Mitomycin and fluorouracil in combination with concomitant radiotherapy: A potentially curable approach for locally advanced head and neck squamous cell carcinoma. Japanese Journal of Clinical Oncology 35 (10): 572-579; 2005.
25. Bhatt M.L.B., Singh K.R., Cornelissen G., Srivastava M. Rai, G. Singh R. Halberg Francine, JarmilaSiegelova, BohumilFiser, Jiri Dusek and Franz Halberg. Chrono-radiotherapy Guided by Circadian Rhythm in Tumor Temperature. Kongresove Centrum, Brno. 19-19; 2005.
26. Madhup R, Kirti S, Bhatt MLB, Srivastava PK, Srivastava M, Kumar S. Letrozole for brain and scalp metastases from breast cancer- A case report.Breast15 (3): 440- 442, 2006.
27. Madhup R, Srivastava K,Bhatt MLB, Srivastava M, Sudhir S, Srivastava AN.Giant ameloblastoma of jaw successfully treated by radiotherapy- Case report. Oral Oncology EXTRA 42: 22- 25, 2006.
28. Kundan S.Chufal,RastogiM,Srivastava,PantMC,BhattMLB. Late chemo-intensification with Cisplatin and 5 Fluorouracil (5- FU) as an adjunct to radiotherapy: A pragmatic approach for locally advanced head and neck squamous cell carcinoma. Oral Oncology42 (5): 517-525, 2006.
29. Pant MC, Shah PP, Singh AP, Singh M, Bhatt MLB, Pant R, Gupta S, Bisht SS, Rastogi Mand Parmar D. Association of Functionally Important Polymorphisms of Tobacco Responsive Cytochrome P 450 and Glutathione-S-Transferases with Head & Neck Cancer. UICC world Cancer Congress Proceeding of the Free Papers Washington, D. C USA, Medimond International Proceedings, 8-12, July 2006.
30. Pant MC, Bisht SS, Pant R, Bhatt MLB, Gupta S, Rastogi M and Shah PP. Cancer Prevention and Tobacco Control: Role of School Education in a Rural Community. UICC world Cancer Congress Proceeding of the Free Papers Washington, D. C USA, Medimond International Proceedings 8-12, July 2006.
31. Bhatt MLB, Srivastava M, Singh S, Pant MC, Rai G, Gupta S, Srivastava K and Dalela D. Synchronous Chemoradiotherapy for muscle invasive urinary bladder carcinoma as an approach to organ conservation. UICC world Cancer Congress Proceeding of the Free Papers Washington, D. C USA, Medimond International Proceedings 8-12; 2006.
32. Kundan S, Chufal, Rastogi M, Srivastava M, Pant M, Bhatt MLB, Srivastava K. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: Impact of nodal density and total tumor volume Japanese Journal of Clinical Oncology36 (9): 537- 546,2006.
33. Rastogi M; Bhatt MLB; Chufal KS; Srivastava M, Pant MC; Srivastava K; Mehrotra S.Esthesio-neuroblastoma Treated with Non-Craniofacial Resection Surgery Followed by Combined Chemotherapy and Radiotherapy: An Alternative Approach in Limited Resources. Japanese Journal of Clinical Oncology36 (10): 613- 619, 2006.
34. Madhup R, Bhatt MLB, Srivastava M, Srivastava K, Pant MC, Srivastava PK.Endobronchial Carcinoid Managed by Surgery and Radiation Therapy - A Case Report. European Journal of Radiology Extra 59 (1): 11- 13; 2006.
35. Rastogi M, Srivastava K, BhattMLB, Srivastava M, Pant MC, Kakkar L. Entero-anal fistula: A rare complication after abdominoperineal resection and radiotherapy. European Journal of Radiology Extra 61 (2): 53-55; 2007.
36. Kundan S Chufal, Rastogi M, Srivastava M, Pant MC, Bhatt MLB, Srivastava K. Concurrent chemoradiotherapy for locally advanced cervical cancer using gemcitabine: nonrandomized comparison of three sequential protocols. Cancer Therapy 5: 43-54, 2007.
37. Bhatt MLB, Matin A, Srivastava M, Pant MC, Srivastava K, Gupta S, Rastogi M, Singh U and Chhavi. Evaluation of Gemcitabine versus Cisplatinum as an adjunct to radiotherapy in locally advanced carcinoma uterine cervix. Journal of Clinical Oncology 25 (18 Suppl): 16012- 16012; 2007.
38. Gupta A, BhattMLB and Misra MK.Lipid peroxidation and antioxidant status in head and neck squamous cell carcinoma patients.Oxidative Medicine and Cell Longevity 2 (2): 68-72, 2009.
39. Shukla P, Gupta D, Bisht SS, Pant MC, Bhatt MLB, Srivastava K, Negi MP. Metastatic squamous cell carcinoma neck with occult primary: A retrospective analysis. Indian Journal of Medical & Paediatric Oncology 30 (4): 124-130,2009.
40. Gupta S, Singh PK, Bisht SS, Bhatt ML, Pant M, Gupta R, Singh S, Negi MPS. Role of recombinant human erythropoietin in patients of advanced cervical cancer treated "by chemoradiotherapy". Cancer Biology and Therapy. 8 (1): 13-17, 2009.
41. D Gupta, P Shukla, SS Bisht, A Aggarwal, A Dhawan, MC pant, Madan L Bhatt, Rajeev Gupta, Kirti Srivastava, Seema Gupta, Madhu Srivastava. Cancer Biology and Therapy 8 (9): 759- 764; 2009.
42. Chufal KS, Rastogi M, Singh S., Pant MC, Srivastava M, Bhatt MLB. Exploring new potentials and generating hypothesis for management of locally advanced head neck cancer: Analysis of pooled data from two phase II trials.Journal of Cancer Research & Therapeutics6 (2): 185-193, 2010.
43. Chhavi, Saxena M, Negi MPS, Singh S, Singh PK, Singh U, Bhatt MLB. DNA content can improve the detection and prognosis of carcinoma of the cervix. BioScience Trends 4 (3): 103-109, 2010.
44. Chhavi, Saxena M, Trivedi R, Negi MPS, Srivastava AK, Bisht S, Singh RK, Chatopadhyay N, Bhatt MLB. Expression Profiling of G2/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of the patients. Journal of Cancer Research and Therapeutics 6 (2): 167-170,2010.
45. Singh PK, Rath SK, Bhatt MLB. Whole genome expression data from human urinary bladder cancer. Gene Expression Omnibus (GEO) Accession of data on 21. 8. 2010 at NCBI data base; data series no. GSE 23732, 2010.
46. Ved P., Kant S, Prasad R., Bhatt MLB, Kushwaha RAS, Hasan G. A Randomized Study of Gemcitabine Monotherapy versus Cisplatin/ Etoposide in the treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer. Journal of Biomedical Sciences & Research2 (3): 119-125;2010.
47. Gupta S, Singh PK, Bhatt MLB, Pant MC, Sunder S., Verma J., Paul S, Kumar D, Shah A, Gupta R. Clinical benefits of two different dosing schedules of recombinant human erythropoietin in anemic patients with advancedheadandneckcancer.BioScience Trends 4 (5): 267-272,2010.
48. Gupta S, Singh PK, Bhatt MLB, Pant MC, Sunder S, Verma J, Paul S, Kumar D, Shah A, Gupta R. Efficacy of Granulocyte Colony Stimulating Factor (G-CSF) as a secondary prophylaxis along with Full-Dose Chemotherapy Following a Prior Cycle of Febrile Neutropenia.BioScience Trends 4 (5): 273- 278, 2010.
49. MehdiSR andBhattMLB. Metastasis of Solid Tumors in Bone Marrow: A Study from Northern India.Indian Journal of Hematology and Blood Transfusion27: 93-95, 2010.
50. Sinha MK, Garg RK, Bhatt MLB, Chandra A. Tumefactive demyelinating lesion: experience with two unusual patients. Postgraduate Medicine 56 (2): 146-149, 2010.
51. Gupta A, Bhatt MLB, Misra MK. Assessment of free radical mediated damage in head and neck squamous cell carcinoma patients after treatment with radiotherapy. Indian Journal of Biochemistry & Biophysics47 (2): 96-99, 2010.
52. Shukla P, Gupta D, Bisht SS, Pant MC, Bhatt MLB, Gupta R, Srivastava K, Gupta S, Dhawan A, Mishra D, Negi MP. Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma.Cancer116 (8): 2031-2035,2010.
53. Gupta A, Verma J, Bhatt MLB, Misra MK. Redox Status and Ascorbic Acid Correlates to Clinical Response in Head and Neck Cancer. The Open Clinical Cancer Journal 4 (1): 1- 2,2010.
54. Gautam S, Bhatt MLB, Singh R, Mehrotra, Singh U, Saxena JK, Singh RK. Impact of therapeutic intervention on oxidants & antioxidants status in patients with ovarian malignancy. Biomedical Research 22 (3): 259-262, 2011.
55. Singh PK, Srivastava A, Singh P, Singh D, Dalela D, Goel M, Gupta S, Negi MPS, Bhatt MLB, Rath S. Clinical utility of survivin gene expression in patients with transitional-cell carcinoma of the urinary bladder. European Journal of Cancer Supplement 9 (1): 4-5; 2011.
56. Srivastava VK, Gara RK, Bhatt MLB, Sahu DP, Mishra DP. Centchroman inhibits proliferation of head and neck cancer cells through the modulation of PI3K/ mTOR pathway. Biochemical and Biophysical Research Communication 404 (1): 40- 45, 2011.
57. Singh PK, Srivastava A, Singh P, Singh D, Dalela D, Goel M, Gupta S, Negi MPS, Bhatt MLB, Rath S. Diagnostic and prognostic potential of CK20 gene expression in patients with transitional-cell carcinoma of the urinary bladder. European Journal of Cancer Suppl. 9 (1): 4- 5, 2011.
58. AK Srivastava, PK Singh, P Singh, D Singh, MLB Bhatt, D Dalela, MM Goel, Shwetank Gupta, MPS Negi and SK Rath. Clinical experience with UCA1 as a biomarker for non-muscle invasive bladder cancer. European Urology Supplements. 10 (2): 74; 2011.
59. Pal P, Kanaujiya JK, Lochab S, Tripathi SB, Bhatt MLB, Singh PK, Sanyal S, Trivedi AK. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562. Proteomics 11(8): 1517-1529, 2011.
60. Gupta S, Singh PK, Khan H, Bhatt MLB, Pant MC, Sundar S, Verma J, Negi M. Positive response to bevacizumab with selective bladder conservation in recurrent and metastatic bladder cancer. European Urology Supplement 10 (2): 211; 2011.
61. Gupta S, Singh PK, Bhatt MLB, Pant MC, Sundar S, Verma J, Negi MPS. Clinical benefits of Epoetin beta in patients with advanced stage hormone refractory prostate cancer. European Urology Supplements10 (2): 337; 2011.
62. Ram H, Sarkar J, Kumar H, Konwar R and Bhatt MLB. Oral Cancer: Risk Factors and Molecular Pathogenesis. Journal of Maxillofacial and Oral Surgery. 10 (2): 132-137, 2011.
63. Gupta D, Shukla P, Bisht SS, BhattMLB, Pant MC, Srivastava K. Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy. Indian Journal of Pharmacology. 43 (4): 478- 480; 2011.
64. Mohammad S, Ram H., Narayan P., Hussain N., Bhatt MLB. Overexpression of COX-2 in oral squamous cell carcinoma patients undergoing chemoradiotherapy. National Journal of Maxillofacial Surgery. 2;1: 17-21, 2011.
65. Madan E., Gogna R., Bhatt M, Pati U., Kuppusamy P., Mahdi A. Regulation of Glucose metabolism by p53: Emerging new roles for the tumor suppressor. Oncotarget, 2; 12: 948-957, 2011.
66. Lochab Savita, Pal Pooja, Kanaujia J K, Tripathi S B, Kapoor Isha, Bhatt MLB, Sanyal S and Trivedi Arun K. Proteomic Identification of E 6 AP as a molecular target of tamoxifen on MCF 7 cells. Proteomics. 12 (9): 1363- 1377, 2012.
67. Bhatt MLB, Kant Surya and Bhaskar Ravi. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian Journal Cancer. 1 (I): 36- 42, 2012.
68. Kar Parmita, Agnihotri Saurabh Kumar, Sharma Archana, Sachan Rekha, Bhatt MLB and Sachdev Monika. A protocol for stripping and re-probing of Western blots originally developed with Colorimetric substrate TMB. Electrophoresis. 33: (19-20): 3062- 3065, 2012.
69. E. Madan, R. Gogna, P. Kuppuswamy, M. Bhatt, U. Pati and A.A. Mahdi. TIGAR induces p53 mediated cell-cycle arrest by regulation of RB-E2F1 complex. British Journal of Cancer 107 (3), 516-526, 2012.
70. Madan Esha, GognaRajan, KuppusamyPeriannan, Bhatt MLB, Mahdi Abbas, and Pati Uttam. SCO2 Induces p53-Mediated Apoptosis by Thr845 Phosphorylation of ASK-1 and Dissociation of ASK-1-TRX Complex. Molecular and Cellular Biology. 33 (7): 1285-1302, 2013.
71. Kanaujia JK, Lochab S, Kapoor I, Pal P, Datta D, Bhatt MLB, Sanyal S, Behre G, Trivedi AK. Proteomic identification of Profilin-1 as a co-expressor of estrogen receptor alpha in MCF-7 breast cancer cells. Proteomics. 13 (14): 2100-2112; 2013.
72. Bhatt MLB, Srivastava Vikas Kumar, Mishra Durga Prasad, Goel Madhu Mati, Mehrotra Divya, Srivastava Kirti, Gara Rishi Kumar.Significance of plasma osteopontin (OPN) as a biomarker in squamous cell carcinoma of tongue. Journal of Clinical Oncology 31 (15 Suppl), e17020- e17020; 2013.
73. Ram H, Kumar M, Bhatt MLB, Shadab M. Oral metastasis from carcinoma cervix. BMJ Case Reports. 2013. bcr – 2013.010020; 2013.
74. Srivastava AK, Singh PK, Dalela D, Rath SK, Goel MM, Bhatt MLB. Diagnostic role of survivin in Urinary Bladder cancer. Asian Pacific Journal of Cancer Prevention 14 (1): 81-85, 2013.
75. Srivastava K, Paul S, Chufal KS, Shamsunder SD, Lal P, Pant MC, Bhatt MLB, Singh S, Gupta R. Concurrent Chemoradiation versus Radiotherapy alone in cervical carcinoma: A randomized phase-III trial. Asia Pacific Journal of Clinical Oncology. 9 (4): 349- 356, 2013.
76. C. Saumya, S. Priyanka, Goel M.M, M. Annu, Seema N, G Shalini, Bhatt. M. Serum Vascular Endothelial Growth Factor C and D in patients with oral Squamous Cell Carcinoma. South Asian Journal of Experimental Biology 3 (4): 195-199; 2013.
77. Yusuf M, Kumar A, Bhatt MLB, Chandra A, Kant S and Ali W. Assessment of Protein C, Protein S and Prothrombin levels in gastrointestinal carcinoma with and without metastasis. Clinical Cancer Investigation Journal 2 (1): 25-28; 2013.
78. Yusuf Mohd., Kumar Ashutosh, Kushwaha Rashmi, Bhatt MLB, Chandra Abhijit, Kant Surya and Siddiqui Zainab. Prospective study on Clotting Factors in selected non-hematological malignancies. Biomedical Research 24 (4): 445-448, 2013.
79. D. Kumar, Pant M.C., Jamal N, Kumar S., Singh S. Bhatt M.L.B. Analytical Study to see effect of Nandrolone Decanoate in patients of Advanced Stage Carcinoma Head and Neck undergoing Therapy (RT/CT). Radiotherapy and Oncology 106: S-22; 2013.
80. Chandra Saumya, Goel Madhu Mati, MakkerAnnu, Nayak Seema, Shilpi Priyanka, Bhatia Vikram and Bhatt MLB. Lymphangiogenesis in Oral Squamous Cell Carcinoma and Potentially Malignant Oral Lesions. International Journal of Pharma and Bio Sciences. 5 (1): 983- 993, 2014.
81. Kumar D., Pant M., Jamal N, Parmar D., Kumar S, Singh S., Bhatt M. Study of association of polymorphism of CYP P450 2d6 with Head and Neck Cancer and treatment response in patients receiving neoadjuvant chemotherapy (TPF) followed by chemoradiation. International Journal of Research in Medical Sciences 2 (2); 585-589; 2014.
82. Yadav Suresh K., Chaddha Sonia, Bhatt MLB and Sanyal Somali. Pilot study to evaluate oxidative stress in patients of squamous cell carcinoma of head and neck (SCCHN). Indian Journal of Scientific Research (special edition): 81- 83, 2014.
83. Singh PK, Srivastava AK, Dalela D, Rath SK, Goel MM, Bhatt MLB. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma. Immunobiology. 219 (6): 469-474, 2014.
84. Singh PK, Srivastava AK, Dalela D, Rath SK, Bhatt MLB. Quantitative analysis of telomerase activity in exfoliated human urothelial cells of transitional cell carcinoma of urinary bladder. International Journal of Healthcare and Biomedical Research 2 (2): 87- 94; 2014.
85. Srivastava AK, Singh PK, Singh D, Dalela D, Rath SK, Goel MM, Bhatt MLB.Evaluation of urinary XIAP as a diagnostic biomarker of carcinoma of urinary bladder. Tumor Biology 35 (8): 8243– 8248, 2014.
86. Tripathi Chakrapani, Tewari Brij Nath, Kanchan Ranjana Kumari, Singh Baghel Khemraj, Nautiyal Naveen, Shrivastava Richa, Kaur Harbeer , Bhatt MLB and BhadauriaSmrati. Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget 5 (14): 5350- 5368, 2014.
87. Dhasmana A., Qazi Mohd., Sajid Jamal, Mir S. S., Bhatt MLB, Rahman Q., Gupta R., Siddiqui M. H., Lohani M. Titanium dioxide Nanoparticles as Guardian Against Environmental Carcinogen Benzo[alpha] Pyrene. PLOS ONE 9 (9): e107068; 1- 9, 2014.
88. SrivastavaA.K., Singh P. K., Dalela D., Rath S. K., Goel M. M., Bhatt MLB. Appraisal of diagnostic ability of UCA 1 as a biomarker of carcinoma urinary bladder. Tumor Biology 35 (11): 11435- 11442, 2014.
89. Dubey P, Shrivastava R, Tritpathi C, Jain N K, Tewari B N, Lone M V D, Baghel K S, Kumar S, Misra S, Bhadauria S and Bhatt MLB. Cyclo-oxygenase-2 Inhibition Attenuates Hypoxic Cancer Cells Induced M2 Polarization of Macrophages. Cellular and Molecular Biology 60 (3): 10- 15, 2014.
90. Kumar Divyesh, Pant Mohan Chand, Parmar Devendra, Singh Sudhir,Bhatt MLB. Association of polymorphism of CYP450 2D6 with head and neck cancer and treatment response in patients receiving neoadjuvant chemotherapy paclitaxel, cisplatin, 5fu (TPF) followed by chemoradiation. International Journal of Research in Medical Sciences 2 (2): 585- 591, 2014.
91. P Gupta, R Hadi, MLB Bhatt, A Singhal. Corpus callosum giant cell glioblastoma in a young girl: A case report. Asian Journal of Pharmaceutical and Health Sciences 4 (2): 967- 970; 2014.
92. Rastogi N, Gara RK, Trivedi R, Singh A, Dixit P, Maurya R, Duggal S, Bhatt MLB, Singh S, Mishra DP.(6)-Gingerol induced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression.Free Radical Biology and Medicine. 68: 288-301; 2014.
93. VK Srivastava, RK Gara, N Rastogi, DP Mishra, MK Ahmad, S. Gupta, Madhu Mati Goel, Madan Lal Brahma Bhatt. Serum vascular endothelial growth factor-A (VEGF-A) as a biomarker in squamous cell carcinoma of head and neck undergoing chemoradiotherapy. Asian Pacific Journal of Cancer Prevention. 15 (7): 3261-3265; 2014.
94. Gautam Suman, Mahdi A.A., Singh Ranjana, Anjum Baby, Mehrotra Seema, Bhatt MLB, Saxena JK. Assessment of oxidative stress biomarkers in patients with gynecolgical malignancy. World Journal of Pharmacy and Pharmaceutical Sciences. 3 (3): 1405-1413, 2014.
95. Singh PK, Srivastava AK, Dalela D, Rath SK, Goel MM, Bhatt MLB. Expression and Clinical significance of Centrosomal protein 55 (CEP55) protein in human urinary bladder cancer. Immunobiology.220 (1): 103-108, 2015.
96. Singh PK, Srivastava AK, Dalela D, Rath SK, Goel MM, BhattMLB.Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.Immunobiology. 220 (1): 68- 73, 2015.
97. Gara Rishi Kumar, Srivastava Vikas Kumar, Duggal Shivali, Bagga Jaspreet Kaur, Bhatt MLB, Sanyal Sabyasachi and Mishra Durga Prasad. Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway. Journal of Biomedical Science 22: (1), 1-12; 2015.
98. Gupta S, Khan H, Kushwaha VS, Husain N, Negi M, Ghatak A, BhattMLB.Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation.Cancer Biology and Therapy. 16 (9): 1269- 1280, 2015.
99. Kar P, Agnihotri SK, Sharma A, Sachan R, Bhatt MLB, Sachdev M.A Novel Methodology for Stripping and Reprobing of Western Blots Originally Developed with Colorimetric Substrate TMB.Methods in Molecular Biology. 1314: 349- 355, 2015.
100. Rastogi N,Duggal S,Singh SK,Porwal K,Srivastava VK,Maurya R,Bhatt MLB,Mishra DP. Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-Gingerol in cervical cancer cells.Oncotarget.6 (41): 43310- 43225,2015.
101. SinghMahendra Pratap,MisraSanjeev,RathanaswamySiva Prakash,GuptaSameer,TewariBrij Nath,BhattMLB,KumarVijay. Clinical profile and epidemiological factors of oral cancer patients from North India. National Journal of Maxillo-facial Surgery. 6 (1): 21-24, 2015.
102. Verma Teerthraj,Painuly Nirmal Kumar, Mishra Surendra Prasad, Shajahan Mohamed, Singh Navin, Bhatt MLB, Jamal Naseem, Pant MC. Evaluating performanceof algorithms in Lung IMRT: A comparison of Monte Carlo, Pencil Beam, Superposition, Fast superposition and Convolution algorithms. Journal of Biomedical Physics & Engineering. 6 (3): 127- 138; 2016.
103. Verma Teerth Raj, Painuly Nirmal K., Mishra Surendra P., SA Yoganathan, GK Jain, Srivastava A, Singh Navin, Bhatt MLB, Jamal Naseem, Pant M. C.Dosimetric effect of intra-fractional and inter-fractional target motion in lung cancer radiotherapy techniques.International Journal of Cancer Therapy and Oncology 3 (4): 343- 352, 2015.
104. SinghMahendra Pratap,KumarVijay,AgarwalAkash,KumarRajendra,BhattMLB,MisraSanjeev. Clinico-epidemiological study of oral squamous cell carcinoma: A tertiary care centre study in North India.Journal of Oral Biology and Craniofacial Research. 6 (1): 31- 34, 2016.
105. Tewari BN, Singh Baghel K, Tripathi C, Dubey P,Bhatt MLB, Kumar V, Mati Goel M, Singh Negi MP, Misra S.A study on local expression of NF-κB, CCL2 and their involvement in intra-tumoral macrophage infiltration in breast cancer.Cellular and Molecular Biology.62 (2): 116-125; 2016.
106. Malhotra KP, Shukla S, Husain N, Bhatt MLB.Combined Squamo-melanocytic Tumor of the Plantar Surface of the Foot: Histogenetic Insights.American Journal of Dermatopathology. 38 (5): 396- 397; 2016.
107. Roopali, Singh S., Gupta S., Bhatt MLB, Jain M., Saha M., Raturi V. P., Gaur J., Kishan D., Singh R. A Prospective Study Comparing Oxaliplatin & 5-FU with Gemcitabine & Cisplatin in Advanced Stage Carcinoma Gall Bladder. Journal of Medical Science and Clinical Research. 4 (5): 10386-10391, 2016.
108. Kumar Rajendra, Raturi Vijay, Jain Manoj, KishanDewesh, Bhatt MLB. Classic Biphasic Pulmonary Blastoma in an Adult Patient. International J of Science and Research. 5 (3): 80- 84, 2016.
109. Singh Richa, Bhatt MLB, Singh Saurabh Pratap, Kumar Vijay, Goel Madhu Mati, Mishra Durga Prasad, Kumar Rajendra. Evaluation of KiSS1 as a Prognostic Biomarker in North Indian Breast Cancer Cases. Asia Pacific Journal of Cancer Research. 17 (4): 1789-1795, 2016.
110. Kapoor I, Kanaujiya J, Kumar Y, Thota JR, Bhatt MLB, Chattopadhyay N, Sanyal S, Trivedi AK.Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation.Oncotarget. 7 (7): 7640- 7647; 2016
111. Srivastava Anupam Kumar, Singh Pankaj Kumar, Singh Dhramveer, Dalela Divakar, Kumar Srikanta Rath and Bhatt MLB. Clinical Utility of Soluble Fas in Screening for Bladder Cancer. Asia Pacific Journal of Clinical Oncology. 12 (2): 215-221, 2016.
112. Gupta Shalini, Nigam Kumud, Bhatt MLB, Mahdi Abbas Ali. The Interleukin- 174 G/C and 572 G/C Promoter Polymorphism Associated with High Risk of Oral Precancer and Cancer in North Indian Population. International Journal of Innovations in Biological and Chemical Sciences. (8): 13- 24, 2016.
113. Singh Baghel Khemraj, Tewari Brij Nath, Shrivastava Richa, Malik ShowkatAhmad,U-Din Lone Mehraj, Jain Nem Kumar, Tripathi Chakrapani, Kumari Kanchan Ranjana, Dixit Sameer, Singh Kavita, Mitra Kalyan, Singh Negi Mahendra Pal, Srivastava Mukesh, Misra Sanjeev, Bhatt MLB,BhadauriaSmrati. Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP- 1β dependent upregulation of MYO3A gene in breast cancer cells. Oncoimmunology. 5 (7) e1196299; 2016.
114. Singh Richa, Bhatt MLB, Singh Saurabh Pratap, Kumar Rajendra, Srivastava Kirti, Goel Madhu Mati, Mishra Anand. Altered Transcriptional and Translational Levels of NM 23 H1 in North Indian Breast Cancer Females and It's Prognostic Relevance. International Journal of Current Research 8 (7): 34081- 34086, 2016.
115. Akshyaya Pradhan, Rohini Khurana, Singh Abhishek, DevenrajVijayant, Bajpai Jyoti, Bhatt MLB, Mehrotra Sanjay. Study on the role of NT-pro-BNP (Brain -natriuretic peptide) and troponin in the detection of anthracycline induced cardiotoxicity. International Journal of Scientific and Research Publications. 6 (6): 749-757, 2016.
116. Kumar Yogesh,Shukla Nidhi,Thacker Gatha,Kapoor Isha,Lochab Savita,Bhatt MLB, Chattopadhyay Naibedya, Sanyal Sabyasachi, Trivedi Arun Kumar. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3beta-dependent Manner.Molecular Cancer Research. 14 (11): 1097- 1109; 2016.
117. Kumar Rajendra, Raturi Vijay, Jain Manoj, KishanDewesh, Bhatt MLB. Classic Biphasic Pulmonary Blastoma in an Adult Patient. International Journal of Science and Research. 5 (3): 80- 84, 2016.
118. Singh Richa, Bhatt MLB, Singh Saurabh Pratap, Kumar Vijay, Goel Madhu Mati, Mishra Durga Prasad, Srivastava Kirti, Kumar Rajendra. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females. Asian Pacific Journal of Cancer Prevention. 17 (7): 3431-3436; 2016.
119. KshetrimayumSilpa, Srivastava Anand, Kant Surya, Verma Ajay Kumar, Prakash Ved, Bajaj Darshan Kumar, Husain Nuzhat, Bhatt MLB. A study of the sociodemographic, clinical, pathological and radiological profile of lung cancer in a tertiary care center. International Journal of Advances in Medicine 3 (4): 920- 927; 2016.
120. Gupta Seema, Kushwaha Vandana Singh, Verma Sandeep, Khan Huma, Bhatt M.L.B., Hussain Nuzhat, Negi Mahendra Pal Singh, Bhosale Vivek Vidyadhar, GhatakAshim. Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation. Heliyon. 2 (12): e00206. 2016.
121. Soni P, Husain N., Chandra A., Ojha B.K, Bhatt M.L.B, Gupta. RK. Do Phosphatase of Regenerative Liver-3, Matrix Metalloproteinases-2, Matrix Metalloproteinases-9 and Epidermal Growth Factor Receptor-1 predict Response to Therapy and survival in Glioblastoma multiforme. Indian Journal of Pathology and Microbiology 56 (3): 287-293; 2016.
122. S Gupta, MLB Bhatt, S Kumar, A Batra, P Katepogu. Superciliary madarosis in an Indian male with chronic myelogenous leukemia treated with dasatinib- A case report. Indian Journal of Case Reports 2 (3): 75-78; 2016.
123. Janahi EM, Dhasmana A, Srivastava V, Sarangi AN, Raza S, Arif JM,Bhatt MLB,Lohani M, Areeshi MY, Saxena AM, Haque S.In silicoCD4+, CD8+ T-cell and B-cell immunity associated immunogenic epitope prediction and HLA distribution analysis of Zika virus. EXCLI Journal 16: 63-72; 2017.
124. Eram Sheikh, MLB Bhatt and M Tripathi. Role of Nano-curcumin: A Treatment of Cancer. Journal of Medicinal Plants 5 (1): 3 94- 397; 2017.
125. Rastogi M, Khurana R, Revannasiddaiah S, Jaiswal I, Nanda SS, Gupta P, Chufal KS, Bhatt ML.Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50Gy) with or without chemotherapy.Support Care in Cancer. 25 (5): 1439-1443; 2017.
126. S Gautam, MLB Bhatt, S Mehrotra, AA Mahdi, R Singh, KS Pasi and B Anjum. Implication of therapeutic intervention on putative oxidative stress markers in cervical cancer. Journal of Dental and Medical Sciences 16 (2): 86-89; 2017.
127. Lone MUD, Baghel KS, Kanchan RK, Shrivastava R, Malik SA, Tewari BN, Tripathi C, Negi MPS, Garg VK, Sharma M, Bhatt MLB and Bhadauria S. Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2 upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells. Oncogene 36 (13): 1829- 1839; 2017.
128. Goyal Manish, Shukla Pragya, Gupta Deepak, Bisht Shyam, Verma Singh Nar, Tiwari Sunita, Bhatt Lal Madan. Cardiovascular sequel of neck irradiation in head and neck cancer patients. International Journal of Radiation Biology 93, (7): 711-716; 2017.
129. KatiyarTridiv, Maurya S. Shailendra, Hasan Feza, Singh P. Arvind, Khan J. Anwar, Hadi Rahat, Singh Sudhir, Bhatt MLB, Parmar Devendra. Association of Cytochrome P450 1B1 haplotypes with head and neck cancer risk. Journal of Environmental and Molecular Mutagenesis 58 (6); 443-450; 2017.
130. Singh Shankar Sharan, Bhatt ML, Kushwaha Vandana Singh, Singh Anshuman, Kumar Rajendra, Gupta Rajeev, Parmar Devendra. Role of matrix metalloproteinase 13 gene expression in the evaluation of radiation response in oral squamous cell carcinoma. Journal of Carcinogenesis 16 (2): 5-16; 2017.
131. Singh Sharan Shankar, Kumar Rajendra, Kushwaha Singh Vandana, Bhatt MLB, Singh Anshuman, Mishra Anupam, Ram Hari, Parmar Devendra, Gupta Rajiv. Expression of Radioresistant Gene PEG10 in OSCC patients and its Prognostic Significance. Asian Pacific Journal of Cancer Prevention 18 (6): 1513-1518; 2017.
132. Haikerwal Amrita, Bhat Madan LB and Saxena K Shailendra. Reducing the global burden of Dengue: Steps toward Preventive Methods. Archives of Prevention Medicine 2 (1): 028-033; 2017.
133. Kumar Swatantra, Bhatt LB Madan, Saxena K. Shailendra. Global Trends in Emerging Viral Infectious Diseases: Challenges to the Mankind. Science for Society 1(1): 7-12, Published January-April 2017.
134. S Raza, S Jahan, A Dhasmana, ML Brahma Bhatt, M Lohani, JM Arif. Vitamin D receptor gene Bsm1 polymorphism and risk of breast cancer. Biochemical and Cellular Archives 17 (2): 657- 663; 2017.
135. Suman Gautam, Seema Mehrotra, MLB Bhatt, Komal S Pasi, B Anjum and AA Mahdi. Status of oxidant and anti oxidantin patients with Gynaecological malignancy undergoing therapy. IOSR Journal of Pharmacy and Biological Sciences 12 (4) version vii: 9- 13, 2017.
136. Saxena K. Shailendra, Haikerwal Amrita, GaduguSrinivasulu, Bhatt ML Madan. Complementary and alternative medicine in alliance with conventional medicine for dengue therapeutics and prevention. Future Virology 12 (8): 399-402. 2017.
137. Rastogi Madhup, Nanda Swarup Sambit, Gandhi Kumar Ajeet, Dalela Divakar, Khurana Rohini, Mishra Prasad Surendra, Srivastava Anoop, Farzana S., Bhatt Brahma Lal Madan, Husain Nuzhat. Pelvic bone anatomy vs implanted gold seed marker registration for image-guided intensity modulated radiotherapy for prostate carcinoma: Comparative analysis of inter-fraction motion and toxicities. Journal of the Egyptian National Cancer Institute 29 (4): 185- 190; 2017.
138. Soni P., Gupta S., Laeeq S., Bhatt M.L.B. An overview of Potential of In-vitro Studies and Transcriptomics for Cancer. Cancer Reports and Reviews 1 (5): 1- 5, 2017.
139. Barik S., Singh S., Gupta S., Jamal N., Parmar D., Dhawan A., Bhatt M.L.B. Association of Polymorphism of Enzyme Thiopurine Methy1 Transferase in Head and Neck Squamous Cell Carcinoma and Treatment Response to Concurrent Chemo-radiotherapy. Journal of Medical Sciences and Clinical Research 5 (4): 20832- 20841, 2017.
140. Singh R. Srivastava A.K., Dwivedi, S., Bhatt M.L.B., Parmar D. Potentiality of EROD Activity may designate CYP1A1 Level in Screening of Head and Neck Cancer. International Journal of Healthcare and Biomedical Research 5 (2): 32-40; 2017.
141. Raj Yash, Kumar Swatantra, Haikerwal Amrita, Goel Madhu M., Bhatt Madan LB, Saxena Shailendra K. Current Advances in Zika Virus Transmission: Urgency for effective therapeutics and prevention. American Journal of Infectious Diseases 13 (2): 13- 20; 2017.
142. D Tiwari, M Shah, M Barthwal, A Pandey, AK Yadav, A Singh, DK Yadav and MLB Bhatt. Pharyngocutaneous fistula in a glottic carcinoma: A rare initial presentation. Asian Journal of Medical Sciences 8 (6): 42- 44; 2017.
143. S Chhabra, Y Kumar, G Thacker, I Kapoor, S Lochab, S Sanyal, Madan LB Bhatt, Naibedya Chattopadhyay, and Arun K Trivedi. E6AP inhibits G-CSFR turnover and functions by promoting its ubiquitin-dependent proteosome degradation. Biochimica et Biophysica acta (BBA)- Molecular Cell Research. 1864 (10): 1543-1553; 2017.
144. T Verma, NK Painuly, MLB Bhatt, S Srivastava, N Singh, SP Mishra, AK Srivastava, R Singh, D Shrotia. Volume mis-estimation by CT scan: Importance of CT performance in precision lung cancer radiotherapy. Journal of Medical Physics 42 (Suppl 1): 63- 63; 2017.
145. Singh N and Bhatt MLB. Differential expression of transcript isoforms related to diagnosis and prognosis of cancers. Proceeding of International Conference on Cell Death in Cancer and Toxicology. Cancer Medicine. 7 (Supplement S1): 18- 18, 2018.
146. Krishna A, Bhatt MLB, Singh V, Singh S, Gangwar PK, Singh US, Kumar V, Mehrotra D. Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa Versus Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 19 (3): 867- 874. 2018.
147. Kumar Swatantra, Maurya K Vimal, Dandu R Himanshu, Bhatt LB Madan, Saxena K Shailendra. Global Perspective of Novel Therapeutic Strategies for the Management of Neuro-AIDS: Novel drug delivery methods for NeuroAIDS. Biomolecular Concepts 9, (1): 33- 42; 2018.
148. Yadav Suresh Kumar, Singh Sudheer, Gupta Shalini, Bhatt Madan Lal Brahm, Mishra Durga P, Roy D, Sanyal Somali. Modulation of Risk of Squamous Cell Carcinoma Head and Neck in North India Population with Polymorphisms in Xeroderma Pigmentosum Complementation Group C Gene. Journal of Cancer Research and Therapeutics. 14 (3): 651-657; 2018.
149. Akhilesh Krishna, Madan Lal Brahma Bhatt, Vineeta Singh, Shraddha Singh, Pravin Gangawar, Uma Shankar Singh, Vijay Kumar and Divya Mehrotra. Differential Expression of c-fos Proto-oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention 19 (3): 867- 874, 2018.
150. Chowdhry R, Singh N, Sahu DK, Tripathi RK, Mishra A, Singh A, Shyam H, Shankar P, Lal N, Bhatt MLBandKant R.16S rRNALong-Read Sequencing of the Granulation Tissue from Nonsmokers and Smokers- Severe Chronic Periodontitis Patients. Biomed Research International.2018: ID 4832912.
151. Nayak Seema, Bhatt M.L.B., Goel Madhu Mati, Gupta Seema, Mahdi Abbas Ali, Mishra Anupam, Mehrotra Divya. Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy. PLOS One 13 (8), e0202432; 2018.
152. Ashutosh Sharma, Ajay K. Jha, Shachi Mishra, Ankita Jain, Bhavana S. Chauhan, Manoj Kathuria, Kundan S. Rawat, Neeraj M. Gupta, Renu Tripathi, Kalyan Mitra, Monika Sachdev, Madan L. B. Bhatt and Atul Goel. Imaging and Quantitative Detection of Lipid Droplets by Yellow Fluorescent Probes in Liver Sections of Plasmodium Infected Mice and Third Stage Human Cervical Cancer Tissues.Bioconjugate Chemistry 29 (11): 3606–3613, 2018.
153. Singh N, Tripathi AK, Sahu DK, Mishra A, Linan M, Argente B, Varkey J, Parida N, Chowdhry R, Shyam H, Alam N, Dixit S, Shankar P, Mishra A, Agarwal A, Yoo C, Bhatt MLB,Kant R.Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia. Oncotarget13; 9 (54):
154. Singh N, Sahu Dinesh Kumar, Tripathi Ratnesh Kumar, Mishra Archana, Singh Satyaendra Kumar, Chowdhry Rebecca, Gupta Sameer, Mehrotra, Divya, Agarwal Preeti, Goel Madhu Mati, Singh Sudhir, Chaturvedi Arun, Satya Akshay Mishra, Agarwal Prakash, Bajpai Manish, Kant Ravi, Bhatt Madan Lal.Characterization of oral squamous cell carcinoma transcriptome through long read sequencing technology.Cancer Research 78 (13 Supplement):3396-3396;2018.
155. E Sheikh, MLB Bhatt and M Tripathi. Bio-based synthesized characterized monodispersed Curcuma longa silver nanoparticle induces targeted anti-cancer activity in breast cancer cell lines. Pharmacognosy Magazine 14 (57): 340- 345; 2018.
156. SS Nanda, M Rastogi, A Gandhi, R Khurana, K Sahni, R Hadi, SP Mishra, AK Srivastava, S Farzana and MLB Bhatt. Impact of reduced PTV margins on toxicity in prostate carcinoma treated with image guided IMRT. Radiotherapy and Oncology 127, S845- S846; 2018.
157. Gupta Ravi, Anand Akshya, Kumar Manoj, Bhatt MLB, Singh Sudhir, Sonkar Abhinav Arun. Safety and efficacy of low-dose single-agent capecitabine in inoperable gallbladder cancer with jaundice post-single-system single-catheter external biliary drainage: a pilot study from am highly endemic area. Indian Journal of Surgical Oncology 9 (4): 530- 537; 2018.
158. P Dubey, SS Singh, SA Malik, M Asif, J Miyan, R Gupta, A Mishra, V Kumar, H Ram, S Bhadauria and MLB Bhatt. Association of aldehyde dehydrogenase with response to radiotherapy in head and neck squamous cell carcinoma. Cancer Medicine 7, 43- 43; 2018.
159. VK Srivastava, N Rastogi, IJ Saifi, P Saxena, MK Ahmed, DP Mishra andMLB Bhatt.Erastin mediated non-apoptotic cell death in head and neck cancer stem cells. Cancer Medicine 7, 56-56; 2018.
     
     
160. Kumar Rajendra, Singh Aparna, Singh Alankrita Singh Geeta, Bhatt M.L.B. A Retrospective Analysis of advance lung carcinoma in north india population with emphasis to its emerging risk in the rural retreat. International Journal of Emerging Technology and Innovative Research. 5 (9): 244-246, 2018.
161. Bhardwaj Shipra, Verma Narsingh,Bhatt Madan Lal Brahma, Rastogi Madhup. A10273 Chronobiological analysis of Blood Pressure for early detection of Chemotherapy induced Cardiotoxicity. Journal of Hypertension 36, e194- e195; 2018.
     
     
162. Yadav Suresh Kumar, Gupta Shalini, Bhatt Madan Lal Brahma, Mishra Durga Prasad, Roy Dayalanand and Sanyal Somali. Single Nucleotide Polymorphism MSH3 Gene Alters Head and Neck Squamous-Cell Carcinoma Risk in North-India. International Journal of Cancer Research 14 (1): 27- 31; 2018.
163. SK Saxena, A Haikerwal, S Kumar andMadan LB Bhatt. Human Influenza A virus infection- Global prevalence, prevention, therapeutics and challenges. Influenza Therapeutics and Challenges. 1; 2018.
     
     
164. SK Saxena, S Kumar, MM Goel, A Kaur and Madan LB Bhatt. Recent advances in human papilloma virus infection and management. Current Perspectives in Human Papillomavirus. IntechOpen 1- 13, doi: 10.5772/ intechopen.81970; 2018.
165. SS Nanda, AK Gandhi, M Rastogi, R Khurana, R Hadi, K Sahni, SP Mishra, AK Srivastava, Madan Lal Brahma Bhatt and Devendra Parmar. Evaluation of XRCC1 gene polymorphism as a biomarker in head and neck cancer patients undergoing chemoradiation therapy. International Journal of Radiation Oncology, Biology and Physics. 101 (3): 593- 601; 2018.
166. D Parmar, V Yadav, F Hasan, S Singh, MLB Bhatt, R Hadi, T Katiyar.Polymorphism in drug metabolizing genes as biomarkers for predicting susceptibility to tobacco induced cancers. Cancer Medicine 7 (Supplement 1): 15-16, 2018.
167. Raza Sana, Dhasmana Anupam, Bhatt Madan Lal Brahma, LohaniMohtashim, Arif M Jamal. Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer. Asian Pacific Journal of Cancer Prevention. 20 (1): 199-206, 2019.
168. S Kumar, Madan LB Bhatt and SK Saxena. Global trends in emerging viral infectious diseases: Challenges to the mankind. RASSA Journal of Science for Society 1 (1 and 2): 7-12; 2019.
169. Shukla Saumya, Pandey Rahul Kumar, Kant Surya, Garg Rajiv, Anand Nidhi, Kushwaha Ram Awadh Singh, Malhotra Kiran Preet, Srivastava Anand, Bhatt Madan Lal Brahma, Husain Nuzhat. Detection of Anaplastic Lymphoma Kinas Gene Re-Arrangement in Non-Small Cell Lung Carcinoma in the Indian Population: Comparison of Techniques and Immunohistochemistry Clones, Turkish Journal of Pathology 35 (1): 36- 45; 2019.
170. RV Parshuram, R Kumar,MLB Bhatt, R Singh, D Parmar, J Gaur, D Kishan, M Shah, Roopali, Pranay Katepogu, Prasad Sentamizh, and TridivKatiyar. To investigate the affiliation of XRCC-1 gene Arg 194Trp polymorphism in alcohol and tobacco substance users and loco-regionally progressed laryngeal squamous cell carcinoma. Journal of Oral Biology and Craniofacial Research 9 (1): 77- 80; 2019.
     
     
171. TR Verma, NK Painuly, SP Mishra, SA Yoganathan, N Singh, MLB Bhatt. Evaluation of lung density and its dosimetric impact on lung cancer radiotherapy: A simulation study. Journal of Biomedical Physics and Engineering 9 (1): 17- 28; 2019.
172. Srivastava S, Painuly NK, Mishra SP, Srivastava K, Singh N, Bhatt MLB. Effect of different definitions of prescription point "A" in high dose rate brachytherapy for cervical cancer.
173. Journal of Cancer Research and Therapeutics. 5 (6): 1365-1369; 2019.
175. Srivastava S, Painuly N. K., Mishra S. P., Srivastava K, Singh N, Bhatt M.L.B. Evaluation of Volumetric Doses of Organs at Risk in Carcinoma Cervix Patients with HDR Intracavitary Brachytherapy and Comparison of CT based and Conventional Plans. Journal of Biomedical Physics & Engineering. 9 (6): 603- 612, 2019.
176. Nigam Kumud, Sanyal Somali, Gupta Shalini, Gupta Om Prakash, Mahdi Abbas Ali,Bhatt MLB, Alteration of the Risk of Oral Pre-Cancer and Cancer in North India Population by CYP1A1 Polymorphism Genotypes and Haplotype. Asian Pacific Journal of Cancer Prevention. 20 (2): 345- 354; 2019.
     
177. Saxena S.K. Kumar S, Sharma R, Maurya VK, Dandu HR,Bhatt MLB. Zika Virus Disease in India- Update October 2018. Travel Medicine and Infectious Disease. 27:121-122. 2019.
     
     
178. Chowdhry Rebecca, Singh Neetu, Sahu Dinesh Kumar, Tripathi Ratnesh Kumar, Mishra Archana, Singh Anjana, MukerjeeIndrashis, Lal Nand, Bhatt Madan Lal Brahma, Kant Ravi. Dysbiosis and Variation in Predicted Functions of the Granulation Tissue Microbiome in HPV Positive and Negative Severe Chronic Periodontitis. BioMed Research International, Volume 2019, Article ID 8163591, 12 pages, DOI 10.1155/20198163591, 2019.
179. Hasan F, Katiyar T, Maurya SS, Yadav V, Yadav S, Pandey R, Mehrotra D, Hadi R, Singh S, Madan L Bhatt, Parmar D. Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients. Biomarkers 24 (6): 574- 583; 2019.
180. Yadav Suresh K, Gupta Shalini, Yadav Angad, Bhatt Madan L.B., Mishra Durga P, Roy D, Sanyal Somali. Endothelial Nitric Oxide Synthase Gene Polymorphisms Modulate the Risk of Squamous Cell Carcinoma of Head and Neck in North Indian Population. Meta Gene 21, 100575; DOI: 10.1016/j.mgene.2019.100575, 2019.
181. Rastogi Madhup, Nanda Sambit Swarup, Gandhi Ajeet Kumar, Dalela Divakar, Khurana Rohini, Mishra Surendra Prasad, Rath Satyajeet, Bhatt Madan Lal Brahma. Impact of Planning Target Volume Reduction on Toxicity and Outcome in Prostate Carcinoma Treated with Image Guided-Intensity Modulated Radiotherapy. Journal of Clinical and Diagnostic Research 13 (6): XC01-XC06; 2019.
182. Maurya K. Vimal, Kumar Swatantra, Bhatt LB Madan, Saxena K. Shailendra. Molecular Mechanism of Neuropathogenesis and current therapeutics for NeuroAIDS, Research Report; 1; e1-e8. DOI; 10.9777/rr.2017.10013; 2019.
183. Singh Rahul, Bhatt Madan Lal Brahma, Kumar Rajendra, Srivastava Kirti, Grover RK, Shukla Pragya, Raturi Vijay P, Roopali, Gaur Jalal, Saha Mandira, KishanDewesh. A Prospective Randomized Comparison of Concurrent Chemoradiation with neoadjuvant and adjuvant chemotherapy with concurrent chemoradiation alone for locally advanced carcinoma cervix. Indian Journal of Medical and Pediatric Oncology 40 (3): 353- 357; 2019.
184. K Nigam, SK Yadav, FM Samadi, MLB Bhatt, S Gupta and S Sanyal. Risk modulation of oral pre cancer and cancer with polymorphism in XPD and XPG genes in north Indian population. Asian Pacific Journal of Cancer Prevention. 20 (8): 2397- 2403; 2019.
185. M Rastogi, AK Gandhi, B Dua, KS Chufal, M Srivastava, S Singh, R Gupta and Madanlal B Bhatt. A prospective randomized study of clinical outcome and toxicity patterns of head and neck squamous cell carcinoma treated with accelerated fractionated radiotherapy versus concurrent chemoradiotherapy. Journal of Clinical and Diagnostic
186. Batra Dhruv, Malhotra Hardeep S, Garg Ravindra K., Malhotra Kiran P., Kumar Niraj, Bhatt Madan L. Brahma, Verma Rajesh, Sharma Praveen K., Rizvi Imran. The Spectrum of malignancies presenting with neurological manifestations: A prospective observational study. Journal of Family Medicine and Primary Care 8 (11): 3726- 3735; 2019.
187. K Nigam, SK Yadav, S Gupta, MLB Bhatt, FM Samadi and S Sanyal. Alteration of the risk of oral pre-cancer and
188. SK Saxena, S Kumar, VK Maurya, and Madan LB Bhatt. The global distribution and burden of dengue and Japanese encephalitis co-infection in acute encephalitis syndrome. Project on: Japanese Encephalitis: Current topics in Neglected Tropical Diseases, pp. 1-10; doi: 10.5772/ intechopen-89792; 2019.
189. Verma TR, Painuly NK, Tyagi M, Johny D, Gupta R,Bhatt MLB.Validation of the Gel & Wax Boluses and Comparison of their Dosimetric Performance with Virtual Bolus. Journal of Biomedical Physics and Engineering 9 (6): 629-636; 2019.
     
     
190. Rastogi N, Gara RK, Trivedi R, Singh A, Dixit P, Maurya R, Duggal S, Bhatt MLB, Singh S, Mishra DP.Corrigendum to “(6)- Gingerol induced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression” [Free Radical Biology and Medicine 68 (2014) 288-301] Article August 2019
     
     
191. D Chakrabarti, S Rajan, N Akhtar, V Kumar, R Kumar, K Srivastava, MLB Bhatt, R Gupta.Long-course chemoradiation in carcinoma rectum; is it really worth it? Perspectives from a developing nation. Annals of Oncology 30 (supplement 4), iv5, 2019.
192. Feza Hasan,Vinay Yadav, TridivKatiyar,Sanjay Yadav,Rahul Pandey, Divya Mehrotra,Rahat Hadi,Sudhir Singh,Madan LB BhattandDevendra Parmar. Validation of gene expression profiles of candidate genes using low density array in peripheral blood of tobacco consuming head and neck cancer patients and auto/taxi drivers with preneoplastic lesions. Genomics 112 (1): 513-519; 2020.
193. Saxena S. K., Mauyra V.K., Kumar S., Bhatt M.LB.. Modern Approaches in Nanomedicine for NeuroAIDS and CNS Drug Delivery. NanoBioMedicine, 199- 211; DOI:10.1007/978-981-32-9898-9_8. February 04, 2020.
194. T Katiyar, V Yadav, SS Maurya, M Ruwali, M Singh, F Hasan, R Pandey, D Mehrotra, S Singh, S Mishra, R Hadi, Madan LB Bhatt, Devendra Parmar. Interaction of Glutathione-s-transferase genotype with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome. Environmental and Molecular Mutagenesis 61 (5): 574- 584; 2020.
195. Kumar Swatantra, Maurya Vimal K, Prasad Anil K, Saxena Shailendra K, Bhatt Madan L.B. Structural glycosylation and antigenic variation between 2019 novel coronavirus(2019-nCoV) and SARS Corona Virus (SARS-CoV). Indian Virological Society 2020. DOI:10.1007/s13337-020-00571-5. March 5, 2020
196. Singh Saurabh Pratap, Singh Richa, Gupta Om Prakash, Gupta Shalini, Bhatt Madan Lal Brahma. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells. Journal of Oncology. Volume 2020, Article ID 3963561, 15 pages, 2020. Doi.org/10.1155/2020/3963561. Page 15. DOI: 10.1155/2020/3963561, 2020.
197. Saxena Shailendra K, Kumar Swatantra, Maurya Vimal K., Sharma Raman, Dandu Himanshu R, Bhatt Madan L.B. Current Insight into the Novel Coronavirus Disease 2019 (COVID-19). Corona Virus Disease 2019 (COVID 2019), 1- 8; 2020.
198. Maurya Vimal K, Kumar Swatantra, Bhatt Madan L.B, Saxena Shailendra K. Therapeutic Development and Drug for the Treatment of COVID-19. Corona Virus Disease 2019 (COVID 19), 109- 126; 2020.
199. Maurya Vimal K, Kumar Swatantra, Prasad Anil K,Bhatt Madan L.B., Saxena Shailendra K. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virus Diseases, 1-15; 2020.
     
     
200. Swatantra Kumar,Vimal K Maurya, Debadatta Nayak²,Anil Khurana²,Raj K Manchanda, SrinivasuluGadugu,Madan L B Bhatt,Shailendra K Saxena.Calcareacarbonica treatment rescues lipopolysaccharide-induced inflammatory response in human mononuclear cells via downregulation of inducible cyclooxygenase pathway.Journal of Integrative Medicine 18 (5): 441- 449; 2020.
     
     
201. V Raturi, H Hojo,MLB Bhatt, M Suhel, CT Wu, Y bei, M Nakamura, M Okumura, H Zhang, D Parmar, A Badajena, R Singh, S Kumar, T Katiyar and J Gaur. Prospective evaluation of XRCC-1 Arg194 Trp polymorphism as bio predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation. Head and Neck 42 (5): 1445-1456; 2020.
     
     
202. N Rastogi, RK Gara, R Trivedi, A Singh, P Dixit, R Maurya, S Duggal,MLB Bhatt, S Singh and DP Mishra. Corrigendum to “(6)- Gingerol induced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression” [Free Radical Biology and Medicine 68 (2014) 288-301] In Free Radical Biology and Medicine 146: 404; 2020.
     
     
203. P Prasad, S Prakash, K Sahu, B Singh, S Shukla, H Mishra, DN Khan, Om Prakash,MLB Bhatt, SK Barik, Mehar H Asif, Samir V Sawant, Amita Jain, Sumit K Bag. Unique mutational changesSARS-CoV-2 genome: A case study for the largest state of India. BioRxiv doi.org/10.1101/2020.08.24. 265827; 2020.
     
     
204. N Singh, DK Sahu, RK Tripathi, A Mishra, H Shyam, P Shankar, M Jain, N Alam, Anil Kumar, Rabeca Chowdary, Anjana Singh, Sameer Gupta, D Mehrotra, Preeti Agarwal, MM Goel, A Chaturvedi, SP Agarwal, M Bajpai, DK Gupta,Madan LB Bhatt and Ravi Kant. Differentially expressed full length, fusion and novel isoforms transcripts-based signature of well differentiated keratinized oral squamous cell carcinoma. Oncotarget 11 (34): 3227-3243; 2020.
     
     
205. Nitu Nigam, Rashmi Kushwaha, Geeta Yadav, Prithvi K Singh, Bhupendra Singh, Monica Agarwal, Pooran Chand, Shailendra K Saxena andMadan Lal Brahma Bhatt. A demographic prevalence of β-Thalassemia carrier and other hemoglobinopathies in adolescent of Tharu population. Journal of Family Medicine and Primary Care 9 (8): 4305- 4310; 2020.
     
     
206. SK Saxena, VK Maurya, S Kumar and MLB Bhatt. Contemporary vaccine approaches and role of next-generation vaccine adjuvants in managing viral diseases. Genomics and Biotechnological Advances in Veterinary, Poultry and Fisheries. 421- 433.http://doi.org/10.1016/B978-0-12-816352-8.00018-7; 2020.
     
     
207. Deep Chakrabarti, SumairaQayoom, DivyaKukreja, Abigail V Resu, Shiv Rajan, Mrinalini Verma, Rajeev Gupta andMadan LB Bhatt. A middle-aged man with adenoid cystic carcinoma: not every dispnoea is the novel corona virus, even during a pandemic. Journal of Radiotherapy in Practice. Pages 3, doi: 10.1017/ S1460396920000801, 2020.
     
     
208. >Ankur Gupta,>Rashmi Karki,>Himanshu R Dandu,>Kuldeep Dhama, Madan LB Bhatt &Shailendra K. Saxena. COVID-19: Benefits and risks of passive immune-therapeutics.https://doi.org/10.1080/21645515.2020.1808410. Received 11 May 2020, Accepted 07 Aug 2020, Published online: 22 Sep 2020.
     
     
209. Sana Raza,Madan Lal Brahma Bhatt,MohtashimLohani and Jamal M Arif. Identification of various risk factors associated with Breast cancer in north Indian women. Biochemical and Cellular Archives 20 (2): 4491- 4496, 2020.
     
     
210. Ankur Gupta, Rashmi Karki, Himanshu R Dandu, Kuldeep Dhama,Madan LB Bhatt and Shailendra Kumar Saxena. Human Vaccines and Immuno-therapeutics, DOI: 10.1080/ 21645515.2020. 1808410. Published online 22 September 2020.
     
     
211. Vimal K Maurya, Swatantra Kumar,Madan L B Bhatt and Shailendra K Saxena. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. Journal of Biomolecular Structure and Dynamics. 2020 Oct 19, 1-17. Doi: 10.1080/07391102.2020.1832577.
     
     
212. Akhtar Naseem, Chakrabarti Deep, Rajan Shiv, Kumar Vijay, QayoomSumaira, Chaturvedi Arun and Bhatt Madan Lal. Is a laryngectomy justified for all histological subtypes of thyroid cancer as a part of gross total excision. Journal of Surgical Oncology123 (7): 1649-1650; 2021.
     
     
213. Prakash S, Prakash O, Mishra H, Khan DN, Shukla S, Pandey A, Rade K, Gupta N, Bhatt MLB, Jain A.Feasibility, efficiency & effectiveness of pooled sample testing strategy (pooled NAAT) for molecular testing of COVID-19.Indian J Med Res. 2021 Jan & Feb;153(1 & 2):227-232. doi: 10.4103/ijmr.IJMR_2333_20.PMID: 33818481, 2021.
     
     
214. Deep Chakrabarti, Naseem Akhtar, Shiv Rajan, SumairaQayoom, Vijay Kumar, Arun Chaturvedi, Rajeev Gupta andMadan LB Bhatt. Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting. Annals of Surgical Oncology. Doi: 10.1245/s10434-020-09512.4, 2021.
     
     
215. RC Joshi, Saumya Yadav, VK Pathak, HS Malhotra, HV Singh Khokhar, Anit Parihar, N Kohli, Himanshu D, RK Garg,Madan LB Bhatt, Raj Kumar, NP Singh, Vijay Sardana, RadimBurget, C Alippi Carlos MT Gonzalez and MK Dutta. A deep learning based COVID19 automatic diagnostic framework using chest x-ray images. Biocybernetics and Biomedical Engineering 41 (1): 239- 254, 2021.
     
     
216. Seema Nayak, Madan Lal Brahma Bhatt, Madhu Mati Goel, Seema Gupta, Divya Mehrotra, Abbas Ali Mahdi, and Anupam Mishra. Aberrant expression PTPN- 14 and Wilms’ Tumor 1as putative biomarker for locoregional recurrence in oral squamous cell carcinoma. Asian Journal of Oncology 2021. DOIhttp://doi.org/10.1055/s- 0041-1731128. ISSN 2454-6798.
     
     
217. Deep Chakrabarti,Naseem Akhtar,Shiv Rajan,SumairaQayoom,Vijay Kumar,Arun Chaturvedi,Mranalini Verm,Rajeev Gupta,Madan Lal Brahma Bhatt,Shirin Parveen.What Is the Acceptable Noninferiority Limit for Nodal Recurrences When Ascertaining Sentinel Lymph Node Biopsy as an Alternative to Neck Dissection for Early Oral and Oropharyngeal Cancers?J Clin Oncol. 2021 May 10;39(14):1599-1600. doi: 10.1200/JCO.20.03439. Epub 2021 Mar 11. PMID: 33705207. DOI:>10.1200/JCO.20.03439.
218. Mukul Mishra, Gatha Thaker, Akshay Sharma, AK Singh, Vishal Upadhyay, Sabyasachi Sanyal, SP Verma, Anil K Tripathi, Madan LB Bhatt and Arun K Trivedi. FBW7 inhibits myeloid differentiation in myeloid leukemia via GSK3-dependent ubiquitination ofPU1.Molecular Cancer Research. Doi: 10.1158/1541-7786.MCR-20-0268 Published February 2021.
     
     
219. Sagar Rai, Zareen Akhtar, Kaushal Kishore Singh,Madan Lal Brahma Bhatt, Sudhir Kumar Verma and Sujita Kumar Kar. Academic loss-related anxiety among college students during COVID-19 pandemic. Indian Journal of Health Sciences and Biomedical Research KLEU. April 2021; 14: 239- 244. DOI: 10.4103/kleuhsj.kleuhsj_398_20.
     
     
220. Bhardwaj Shipra, Verma Narsingh,Bhatt M L B and Rastogi Madhup. Circadian variability and circadian hyper amplitude tension as a early predictive marker of chemotherapy induced cardio-toxicity. Journal of Hypertension. 39-P; e146- e147, 2021.
     
     
221. Chakrabarti D, Rajan S, Akhtar N, Qayoom S, Gupta S, Verma M, Srivastava K, Kumar V, Bhatt MLB, Gupta R.Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial.Br J Surg. 2021: znab020. doi: 10.1093/bjs/znab020. Online ahead of print. PMID: 33724296, 2021.
222. PritiPrasad,ShantanuPrakash,KishanSahu,BabitaSingh,SuruchiShukla,HrichaMishra,Danish NasarKhan,OmPrakash,MLBBhatt,SKBarik,Mehar H.Asif,Samir V.Sawant,AmitaJain.Unique mutational changes in SARS-CoV-2 genome: A case study for the largest state of India.bioRx iv. doi:https://doi.org/10.1101/2020.08.24.265827.
223. MitaliBasak, Sirsendu Mitra, Saurabh Kumar Agnihotri, Ankita jain, Akanksha Vyas,Madan Lal Brahma Bhatt, Rekha Sachan, Monika Sachdev, Harshal B. Nemade and Dipankar Bandopadhyay. Noninvasive Point-of-Care nanobiosensing of cervical cancer as an auxillary to Pap-smear test. ACS Applied Bio Materials. Accepted May 2021. https:// doi.org/ 10.1021/acsabm.1c00470.
     
     
224. Deep Chakrabarti, Mranalini Verma, DivyaKukreja, Mansi Shukla andMadan Lal Brahma Bhatt.Palliative chest wall radiotherapy for a fungating and bleeding metastatic breast cancer: quality of life beyond cure. BMJ Case Report 2021; 14: e243722. Doi: 10.1136/bcr-2021- 243722. Accepted July 2021.
     
225. Agnihotri SK, Kar P, Singh M, Pant G, Mitra K, Bhatt MLB, Sachdev M. Modulation of protein phosphatase 1 gamma 2 during cell division of cervical cancer HeLa cells. Contemporary Oncology (Ponz).2021;25 (2):125- 132. Doi: 10.5114/wo.2021.107745.Epub 2021 Jul 1. PMID: 34667439: PMCID: PMC8506433.
     
226. Pankaj Kumar Singh, Madan Lal Brahma Bhatt, Prabhat Singh, Srikanta Kumar Rath, Diwakar Dalela and Madhu Goel. Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1(hMps1/TTK) in human urinary bladder transitional cell carcinoma. Drug Discoveries and Therapeutics 15 (4) 2021. DOI: 10.5582/ddt2021.01010. August 2021.
227. D. Chakrabarti, M. Verma, D. Kukreja, AV Resu, K. Srivastava, R Gupta and M. L. B. Bhatt. The demographics of cancer care in a developing country: ten-year experience from an academic university hospital in India. Annal of Oncology 32 (SS) S 1106, 1511 P, 2021. DOI:https://doi.org/10.1016/jannonc.2021.08.840, 2021.
228. D. Kukreja, D. Chakrabarti, A.V. Resu, M. Verma, S. Qayoom, S. Rajan, N. Akhtar, R. Gupta and M.L.B. Bhatt. Impact of induction chemotherapy (ICT) in borderline-resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC). Annal of Oncology 32 (SS): S 808, 914 P, 2021. Doi:https://doi.org/10.1016/j.annonc.2021.08.1324. 2021.
229. AseemTikku, Madan Lal Brahma Bhatt, Narendra Kumar Painuly, Ramesh Bharti, Rhythm Bains and SakshamaMisra. Shear bond strength analysis and marginal gap evaluation of restoration- tooth interface of aesthetic restorations after simulated Co-60 gamma irradiation. Journal of Radiotherapy in Practice. September 2021. DOI: 10.1017/S1 460396921000492. 2021.
230. Vinay Kumar Yadav, TridivKatiyar, MunindraRuwali, Sanjay Yadav, Sudhir Singh, Rahat Hadi, Madan Lal Brahma Bhatt and Devendra Parmar. Polymorphism in cytochrome P450 2A6 reduces the risk to head and neck cancer and modifies the treatment outcome. Environmental and Molecular Mutagenesis.62 (9): 502- 511; 2021.http://doi.org/10.1002/em.22466. Oct 2021.
231. Parul Dubey, Rajeev Gupta, Anupam Mishra, Vijay Kumar, SmratiBhadauria and Madan Lal Brahma Bhatt. Evaluation of correlation between CD44, Radiotherapy response and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC). Cancer Medicine. bioRxiv 2021.09.26.461653;http://doi.org/10.1101/2021.09.26.461653.2021.
232. Agnihotri SK, Kumar B, Jain A, Negi MPS, Sachan R,Bhatt ML, Rajkamal Tripathi and Sachdeva M. Clinical significance of circulating serum levels of sCD95 and TNFα in cytoprotection of cervical cancer. Reports of Biochemistry and Molecular Biology. (In Press), 2021.
     
     
233. J S Tuteja,A Anand,D Chakrabarti,R Gupta,M L B Bhatt.Snapshots quiz.British Journal of Surgery, znab329,https://doi.org/10.1093/bjs/znab329. Published: 01 October 2021.
     
     
234. DivyaKukreja, Deep Chakrabarti, Abigail VeravoluResu, Mranalini Verma andMadan Lal Brahma Bhatt. Atypical Herpes Zoster Reactivation in an Elderly Gentleman with Advanced Oral Cancer. Bengal Journal of Cancer 1: 47- 48; 2021.
     
     
235. Pankaj Kumar Singh,Madan Lal Brahma Bhatt, Prabhat Singh, Srikanta Kumar Rath, Diwakar Dalela and Madhu Mati Goel. CASC5 is a potential Cancer-testis gene in human urinary bladder transitional cell carcinoma. Drug Discovery and Therapeutics 15 (6): 331- 336, 2021. Doi: 10.5582/ddt.2021.01108.
     
     
236. Vimal K Maurya, Swatantra Kumar,Madan L B Bhatt and Shailendra K Saxena (2022). Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. Journal of Biomolecular Structure and Dynamics. 40: 4, 1719-1735, DOI: 10.1080/07391102.2020.1832577.
     
     
237. Parul Dubey, N Kumar, R Gupta, A Mishra, S Bhadauria, V Kumar and M L B Bhatt. Association of ALDH1 with response to radiotherapy and its impact on survival in patients with advanced stage squamous cell carcinoma (HNSCC). Asian Pacific Journal of Cancer Prevention. 2021. Manuscript ID- APJCC- 2013- 6712 (R1). DOI: 10.31557/APJCP.2022.23.2.419.
     
     
238. Sadanand Prakash, Deep Chakrabarti, Rajendra Kumar, Manas Mani Agarwal, Mrinalini Verma, Sudhir Singh, Seema gupta, Kirti Srivastava, Rajeev Gupta,Madan Lal Brahma Bhatt. Palliative Radiotherapy: A one-week course in advanced head and neck cancer- quality of life outcomes. BMJ Supportive and Palliative Care. 2022. DOI: 10.1136/bmjspcare-2021-002908.
     
     
239. TridivKatiyar, Vinay Yadav, Shailendra Shankar Maurya, Fezahasan, Arvind P. Singh, Sanjay Yadav, Sudhir Singh, Rahat Hadi,Madan Lal Brahma Bhatt, Devendra Parmar. Interaction of Cytochrome P450s with environmental risk factors increases their expression and risk to head and neck cancer. Environmental and Molecular Mutagenesis May 2022. DOI: 10.1002/em. 2495.
     
     
240. D Chakrabarti, A Ghosh, M Verma, D Kukreja, N Akhtar, S Rajan, S Qayoom, P Ramakant, V Kumar, K Srivastava, R Gupta,ML Bhatt. Outcome of male breast cancer patients at an academic university hospital in India. Radiotherapy and Oncology, 2022.
     http://doi.org/10.1016/S0167-8140(22)03142-5.
     
     
241. D Chakrabarti, S Qayoom, D Kukreja, MM Goel, U Singh, M Verma, K Srivastava,ML Bhatt. Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing radiotherapy. Radiotherapy and Oncology, 2022.
     http://doi.org/10.1016/S0167-8140(22)03323-0.
     
     
242. Mrinalini Verma, Kirti Srivastava, Sanjay Singhal,MLB Bhatt. Problems associated with inadequate surgery in patients with cervical cancer: Can they be avoided? Cancer Research, Statistics and Treatment 5 (1): 145-147; 2022.
     
     
243. Deep Chakrabarti, Mrinalini Verma, DivyaKukreja andMadan Lal Brahma Bhatt. Letter to the editor on ‘Targeted Therapies for Head and Neck Cancers in Developinhg Countries: Where are we actually at? Clinical Oncology. 34 (7), DOI:10.1016/j.clon.2022.02001. February 2022.
     
     
244. Yadav A, Kumar L, Pal US, Singh M, Bhatt ML, Patil R, Verma A. Radio frequency analysis of partially grafted immediate dental implant with and without use of static magnetic field: An in vivo study. Natl J MaxillofacSurg 2022;13, Suppl S1:41-5.
     
     
245. Aneri Parekh, Kunal Deokar, Mrinalini Verma, Sanjay Singhal, Madan Lal Bhatt and CDS Katoch. The 50 Year Journey of Lung Cancer Screening: A Narrative Review. Cureus 14 (9): e29381. Doi:10.7759/cureus.29381. September 2022.

Book Chapters/ Articles published in Scientific Magazines:

1. Radiation Risk from Medical X-Ray Devices, Interventional Radiology and Mammography. S.P. Mishra and M.L.B. Bhatt.Book Chapter in the book: Biological Responses, Monitoring and Protection from Radiation Exposure. Edited by: Prof K P Mishra, Publisher- Nova Sciences Publishers, New York, New York, USA. 2015.
   
   
2. Kar P, Agnihotri SK, Sharma A, Sachan R, Bhatt ML, Sachdev M. A novel methodology for stripping and reprobing of Western Blots originally developed with colorimetric substrate TMB. In Detection of Blotted Proteins 2015 (pp. 349-355). Humana Press, New York, NY.
3. Introductory Chapter: Neglected Tropical Waterborne Infectious Diseases- Strategies for Mitigation. By: Shailendra K. Saxena, Swatantra Kumar, Amrita Halkerwal, Madan L.B. Bhatt. In the book: water Challenges of an Urbanizing World. Water Challenges of an Urbanizing World.Publisher- IntechOpen Online. Chapter 1, 2018.
   
   
4. Introductory Chapter: Human Influenza A virus infection- Global prevalence, prevention, therapeutics and challenges. By: SK Saxena, A Haikerwal, S Kumar and Madan LB Bhatt. In the book: Influenza- Therapeutics and Challenges.Publisher- IntechOpen Online. Chapter1; 2018.
   
   
5. The Global Distribution and Burden of Dengue and Japanese Encephalitis Co-infection in Acute Encephalitis Syndrome. Shailendra Kr. Saxena, Swatantra Kumar, Vimal K. Maurya, and M.L.B. Bhatt.^.DOI:10.5772//Intechopen.89792. October 17, 2019.
   
   
6. Therapeutic Development and Drugs for the Treatment of Covid 19. Vimal Kumar Maurya, Swatantra Kumar,Madan LB Bhatt, and Shailendra Kumar Saxena; in the Book: Corona Virus Disease 2019 (COVID 19), Medical Virology: From Pathogenesis to Disease Control. DOI. Org/ 10.1007/ 978-981-15- 4814- 7_10.
   
   
7. Recent Advances in Human Papilloma Virus Infection and management. By:
8. Shailendra Kumar Saxena, Swatantra Kumar, Madhu Mati Goel, Apjit Kaur andMadan LB Bhatt; in the Book: current Perspective in Human papilloma Virus, Edited by: Shailendra Saxena. Open Access- Peer Reviewed Edited Volume, 2019. DOI: 10.5772/ Intech open. 73828. E Book (pdf) ISBN: 978-1-83880-637-8; Print: ISBN: 978-1-78985-821-1.
   
9. Contemporary vaccine approaches and role of next-generation vaccine adjuvants in managing viral diseases- Genomics and Biotechnological Advances in Veterinary, Poultry and Fisheries. In book: Contemporary vaccine approaches and role of next-generation vaccine adjuvants in managing viral diseases. SK Saxena, VK Maurya, S Kumar and MLB Bhatt. 421- 433. http://doi.org/10.1016/B978-0-12-816352-8.00018-7; 2019.
10. Current Insight into the Novel Coronavirus Disease 2019 (COVID-19). Corona Virus Disease 2019 (COVID 2019). Saxena Shailendra K, Kumar Swatantra, Maurya Vimal K., Sharma Raman, Dandu Himanshu R, Bhatt Madan L.B. 1- 8; 2020.
11. Therapeutic Development and Drug for the Treatment of COVID-19. Corona Virus Disease 2019 (COVID 19). Maurya Vimal K, Kumar Swatantra,Bhatt Madan L.B, Saxena Shailendra K. 109- 126; 2020.
    
    
    
12. Nipah Virus. By: SK Saxena, VK Maurya, S Kumar andMLB Bhatt. In the Book: Animal -Origin Zoonoses, 69- 79, 2020.
    
    
13. Pandemic Influenza A Virus (pH1N1), by: SK Saxena, VK Maurya, S Kumar andMLB Bhatt. In the Book: Animal- Origin Zoonoses, 135- 144, 2020.
    
    
14. COVID-19: Third wave and Beyond- Action Plan: June 2021. Published by Research for Resurgence Foundation, Nagpur.www.rfrfoundation.org. As a task group expert, wrote a report which was submitted to NITI Ayog, with Dr Sarit Das, IIT Madras as Convener. June 2021.
    
    
15. Technical Dossier on Guduchi (Tinosporacordiofolia)- as Chairman of the Committee constituted by Ministry of AYUSH, Published by All India Institute of Ayurveda, an Autonomous Organization under the Ministry of AYUSH and authored by Ministry of AYUSH, Government of India, New Delhi, First Edition 2022.

PROF. Rajeev Gupta

1. Hari R Mali, Rajiv Gupta, Madhu Srivastava, Sahid A Siddiqui, Madan LBBhatt. Synchronous Chemo-irradiation using cis-platin as a cytotoxic agentIn Loco-Regionally Advanced Head & Neck Cancer. Journal of ClinicalRadiotherapy& Oncology Vol 13, No 2: 141-145, 1998
2. Seema Gupta, M.C. Pant, ShyamBisht, Sharad Singh, Rajeev Gupta.Innovative Treatment Strategies in Small Cell Lung Cancer. IndianJournalOf Bio Research Vol. 58 No. 1 pp65-69 January-June 2005
3. Seema Gupta, M.C. Pant, ShyamBisht, Sharad Singh, Rajeev Gupta.Optimization of Chemotherapy and Radiotherapy in Locally AdvancedNon Small cell Bronchogenic Carcinoma. Indian Journal of Bio ResearchVol. 58 No. 1 pp 20-32 January-june 2005.
4. Seema Gupta, M.C. Pant, ShyamBisht, Sharad Singh, Rajeev Gupta.Innovative Treatment Strategies in Small Cell Lung Cancer. IndianJournalOf Bio Research Vol. 58 No. 1 pp65-69 January-June 2005
5. Seema Gupta, M.C. Pant, ShyamBisht, Sharad Singh, Rajeev Gupta.Optimization of Chemotherapy and Radiotherapy in Locally AdvancedNon Small cell Bronchogenic Carcinoma. Indian Journal of Bio ResearchVol. 58 No. 1 pp 20-32 January-june 2005.
6. Chakrabarti D, Resu AV, Pandey A, Gupta R. Carcinoma cervix with cerebellar metastases presenting with pulmonary aspiration: a rare presentation and a rare metastatic site in a common cancer. BMJ Case Rep. 2019 Jul 27;12(7):e229063. doi: 10.1136/bcr-2018-229063. PMID: 31352376; PMCID: PMC6663224.
7. Chakrabarti D, Qayoom S, Ghosh A, Gupta R. Neuroendocrine carcinoma of the gall bladder in a young lady presenting with upper abdominal heaviness: a common complaint and a rare diagnosis. BMJ Case Rep. 2019 Apr 5;12(4):e229684. doi: 10.1136/bcr-2019-229684. PMID: 30954965; PMCID: PMC6453428.
8. Chakrabarti D, Qayoom S, Akhtar N, Gupta R. Squamous cell carcinoma of the rectum. BMJ Case Rep. 2020 Oct 31;13(10):e236256. doi: 10.1136/bcr-2020-236256. PMID: 33130582; PMCID: PMC7783618.
9. Chakrabarti D, Akhtar N, Qayoom S, Rajan S, Kumar V, Gupta R, Chaturvedi A. Optimising elective neck dissection for early oral cancers. Oral Oncol. 2021 Mar;114:105090. doi: 10.1016/j.oraloncology.2020.105090. Epub 2020 Nov 14. PMID: 33199173.
10. Chakrabarti D, Akhtar N, Rajan S, Qayoom S, Kumar V, Chaturvedi A, Verma M, Gupta R, Bhatt MLB, Parveen S. What Is the Acceptable Noninferiority Limit for Nodal Recurrences When Ascertaining Sentinel Lymph Node Biopsy as an Alternative to Neck Dissection for Early Oral and Oropharyngeal Cancers? J Clin Oncol. 2021 May 10;39(14):1599-1600. doi: 10.1200/JCO.20.03439. Epub 2021 Mar 11. PMID: 33705207.
11. Chakrabarti D, Rajan S, Akhtar N, Qayoom S, Gupta S, Verma M, Srivastava K, Kumar V, Bhatt MLB, Gupta R. Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial. Br J Surg. 2021 May 27;108(5):511-520. doi: 10.1093/bjs/znab020. PMID: 33724296.
12. D Chakrabarti, S Rajan, N Akhtar, V Kumar, R Kumar, K Srivastava, MLB Bhatt, R GuptaLong-course chemoradiation in carcinoma rectum; is it really worth it? Perspectives from a developing nation. Annals of Oncology 30 (supplement 4), iv5, 2019.
">
13. Deep Chakrabarti, SumairaQayoom, DivyaKukreja, Abigail V Resu, Shiv Rajan, Mrinalini Verma, Rajeev Gupta and Madan LB Bhatt. A middle-aged man with adenoid cystic carcinoma: not every dispnoea is the novel corona virus, even during a pandemic. Journal of Radiotherapy in Practice. Pages 3, doi: 10.1017/ S1460396920000801, 2020.
14. Deep Chakrabarti, Naseem Akhtar, Shiv Rajan, SumairaQayoom, Vijay Kumar, Arun Chaturvedi, Rajeev Gupta and Madan LB Bhatt. Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting. Annals of Surgical Oncology. Doi: 10.1245/s10434-020-09512.4, 2021.
15. Deep Chakrabarti , Naseem Akhtar,Shiv Rajan,SumairaQayoom,Vijay Kumar,Arun Chaturvedi,Mranalini VermaRajeev Gupta,Madan Lal Brahma Bhatt,Shirin Parveen. What Is the Acceptable Noninferiority Limit for Nodal Recurrences When Ascertaining Sentinel Lymph Node Biopsy as an Alternative to Neck Dissection for Early Oral and Oropharyngeal Cancers?J Clin Oncol. 2021 May 10;39(14):1599-1600. doi: 10.1200/JCO.20.03439. Epub 2021 Mar 11. PMID: 33705207. DOI:10.1200/JCO.20.03439.
16. Chakrabarti D, Rajan S, Akhtar N, Qayoom S, Gupta S, Verma M, Srivastava K, Kumar V,Bhatt MLB,Gupta R.Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial.Br J Surg. 2021: znab020. doi: 10.1093/bjs/znab020. Online ahead of print. PMID: 33724296, 2021.
17. D. Chakrabarti, M. Verma, D. Kukreja, AV Resu, K. Srivastava, R Gupta and M. L. B. Bhatt. The demographics of cancer care in a developing country: ten-year experience from an academic university hospital in India. Annal of Oncology 32 (SS) S 1106, 1511 P, 2021. DOI:https://doi.org/10.1016/jannonc.2021.08.840, 2021.
18. J S Tuteja,A Anand,D Chakrabarti,R Gupta,M L B Bhatt.Snapshots quiz.British Journal of Surgery, znab329,https://doi.org/10.1093/bjs/znab329. Published: 01 October 2021.
19. Sadanand Prakash, Deep Chakrabarti, Rajendra Kumar, Manas Mani Agarwal, Mrinalini Verma, Sudhir Singh, Seema gupta, Kirti Srivastava, Rajeev Gupta, Madan Lal Brahma Bhatt. Palliative Radiotherapy: A one-week course in advanced head and neck cancer- quality of life outcomes. BMJ Supportive and Palliative Care. 2022. DOI: 10.1136/bmjspcare-2021-002908.
20. D Chakrabarti, A Ghosh, M Verma, D Kukreja, N Akhtar, S Rajan, S Qayoom, P Ramakant, V Kumar, K Srivastava, R Gupta,ML Bhatt. Outcome of male breast cancer patients at an academic university hospital in India. Radiotherapy and Oncology, 2022.
    http://doi.org/10.1016/S0167-8140(22)03142-5.

PROF. Kirti Srivastava

1. Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, Mittal B. Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol. 2009 Sep;114(3):501-5. doi: 10.1016/j.ygyno.2009.05.032. Epub 2009 Jun 21. PMID: 19541348.
2. Pandey S, Mittal RD, Srivastava M, Srivastava K, Mittal B. Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population. Int J Gynecol Cancer. 2010 May;20(4):625-30. doi: 10.1111/IGC.0b013e3181c63f79. PMID: 20686383.
3. Agrawal S, Maurya AK, Shrivastava K, Kumar S, Pant MC, Mishra SK. Training the trainees in radiation oncology with telemedicine as a tool in a developing country: a two-year audit. Int J Telemed Appl. 2011;2011:230670. doi: 10.1155/2011/230670. Epub 2011 Apr 26. PMID: 21603023; PMCID: PMC3095242.
4. Abbas M, Srivastava K, Imran M, Banerjee M. Association of Glutathione S-transferase (GSTM1, GSTT1 and GSTP1) polymorphisms and passive smoking in cervical cancer cases from North India. Int Jour of Biomed Res [Internet]. 2013 Dec. 30. Available from:http://ssjournals.com/index.php/ijbr/article/view/905
5. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation AbbasM, KushwahaVS, SrivastavaK, BanerjeeM (2015)Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation. PLOS ONE 10(11): e0142501.https://doi.org/10.1371/journal.pone.0142501
6. Kirti Srivastava, Anuradha Nischal Anupam Wakhlu, Anshita SinghCytotoxic Drug Disposal: Urgent Need For GuidelinesINDIAN SOCIETY OF HOSPITAL WASTE MANAGEMENT. 2012;
7. Reema Kumari, Kirti Srivastava, Anupam WakhluHospital Waste management Journal of Physiology, 2012
8. Srivastava K, Paul S, Chufal KS, Shamsundar SD, Lal P, Pant MC, Bhatt M, Singh S, Gupta R. Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial. Asia Pac J Clin Oncol. 2013 Dec;9(4):349-56. doi: 10.1111/ajco.12078. Epub 2013 May 27. PMID: 23710586.
9. Paul, Sayan, et al. "Post-mastectomy radiotherapy for one to three axillary node positive early breast cancer: To radiate or not to radiate?."Clinical Cancer Investigation Journal, vol. 2, no. 1, Jan.-Mar. 2013, p. 14.Gale Academic OneFile,link.gale.com/apps/doc/A328202874/AONE?u=anon~405b8f4d&sid=googleScholar&xid=15b4f212. Accessed 3 Nov. 2022.
10. Reema Kumari, Kirti Srivastava, Anupam Wakhlu, Anshita Singh,
11. Establishing biomedical waste management system in Medical University of India – A successful practical approach,Clinical Epidemiology and Global Health,Volume 1, Issue 3,2013,Pages 131-136,ISSN 2213-3984,https://doi.org/10.1016/j.cegh.2012.11.004.(https://www.sciencedirect.com/science/article/pii/S2213398412000085)
12. Srivastava AK, Singh PK, Srivastava K, Singh D, Dalela D, Rath SK, Goel MM, Brahma Bhatt ML. Diagnostic role of survivin in urinary bladder cancer. Asian Pac J Cancer Prev. 2013;14(1):81-5. doi: 10.7314/apjcp.2013.14.1.81. PMID: 23534808.
13. Mohd. Abbas, ,K. Srivastava, Mohd. Imran M. BanerjeeAssociation of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian populationEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology, 04 Mar 2014, 176:68-74
    DOI:10.1016/j.ejogrb.2014.02.036 PMID: 24657182
14. Abbas M, Kushwaha VS, Srivastava K, Banerjee M. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation. PLoS One. 2015 Nov 16;10(11):e0142501. doi: 10.1371/journal.pone.0142501. PMID: 26571237; PMCID: PMC4646353.
15. Siddharth Kumar, Sudhir Singh, Abhishek Dubey, K. Srivastava, Disha Tiwari, Rajeev GuptaEffect Of Drug Metabolising Enzyme Cytochrome Cyp2c9 Gene Polymorphism On Treatment Response In Carcinoma Of Oropharynx And Hypopharynx Volume-8 | Issue-2 | February-2018 | 8618 ISSN - 2249-555X | IF : 5.397|IC Value : 86.18
16. Siddharth Kumar, Sudhir Singh, Abhishek Dubey, K. Srivastava, Disha Tiwari, Rajeev GuptaAssociation Of Cytochrome Cyp2c9 Gene Polymorphism In Carcinoma Of Oropharynx And Hypopharynx Volume-7 | Issue-2 | February-2018 | ISSN No 2277 - 8179 | IF : 4.176 | IC Value : 93.98
17. M Abbas, VS Kushwaha, K Srivastava, ST Raza & M Banerjee(2018)Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer,British Journal of Biomedical Science,75:4,169-174,DOI:10.1080/09674845.2018.1482734
18. M Abbas, K Srivastava, M Imran & M Banerjee(2019)Genetic polymorphisms in DNA repair genes and their association with cervical cancer,British Journal of Biomedical Science,76:3,117-121,DOI:10.1080/09674845.2019.1592884
19. Karma Yangchen, Ramashankar Siddharth, Saumyendra V. Singh, Raghuwar D. Singh, Himanshi Aggarwal, Niraj Mishra, Shuchi Tripathi, Kirti Srivastava¹, Teethraj Verma ¹, Pradeep KumarA pilot study to evaluate the efficacy of Cerrobend shielding stents in preventing adverse radiotherapeutic effects in buccal carcinoma patientsJournal of Cancer Research and Therapeutics- January-March 2016- Volume 12- Issue 1[http://www.cancerjournal.net on Tuesday, October 15, 2019,]
20. Badajena A, Raturi VP, Sirvastava K, Hojo H, Ohyoshi H, Bei Y, Rachi T, Wu CT, Tochinai T, Okumura M, Zhang H, Kouta H, Verma P, Singh G, Anand A, Sachan A. Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy. Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):260-265. doi: 10.1016/j.rpor.2020.02.006. Epub 2020 Feb 22. PMID: 32140083; PMCID: PMC7049598.
21. Chakrabarti D, Rajan S, Akhtar N, Qayoom S, Gupta S, Verma M, Srivastava K, Kumar V, Bhatt MLB, Gupta R. Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial. Br J Surg. 2021 May 27;108(5):511-520. doi: 10.1093/bjs/znab020. PMID: 33724296.
22. D. Chakrabarti, M. Verma, D. Kukreja, AV Resu, K. Srivastava, R Gupta and M. L. B. Bhatt.The demographics of cancer care in a developing country: ten-year experience from an academic university hospital in India.Annal of Oncology 32 (SS) S 1106, 1511 P, 2021. DOI:https://doi.org/10.1016/jannonc.2021.08.840, 2021.
23. Srivastava R, Akhtar N, Prakash P, Srivastava K. Malignant Eccrine Spiroadenoma of Right Temporal region: Reporting of a Rare Case. J Maxillofac Oral Surg. 2022 Mar;21(1):102-104. doi: 10.1007/s12663-021-01561-w. Epub 2021 May 11. PMID: 35400905; PMCID: PMC8934780.
24. Sadanand Prakash, Deep Chakrabarti, Rajendra Kumar, Manas Mani Agarwal, Mrinalini Verma, Sudhir Singh, Seema gupta, Kirti Srivastava, Rajeev Gupta, Madan Lal Brahma Bhatt. Palliative Radiotherapy: A one-week course in advanced head and neck cancer- quality of life outcomes. BMJ Supportive and Palliative Care. 2022. DOI: 10.1136/bmjspcare-2021-002908.
25. D Chakrabarti, A Ghosh, M Verma, D Kukreja, N Akhtar, S Rajan, S Qayoom, P Ramakant, V Kumar, K Srivastava, R Gupta,ML Bhatt. Outcome of male breast cancer patients at an academic university hospital in India. Radiotherapy and Oncology, 2022.
    http://doi.org/10.1016/S0167-8140(22)03142-5.
26. D Chakrabarti, S Qayoom, D Kukreja, MM Goel, U Singh, M Verma, K Srivastava,ML Bhatt.Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing radiotherapy.Radiotherapy and Oncology, 2022.
    http://doi.org/10.1016/S0167-8140(22)03323-0.
27. Mrinalini Verma, Kirti Srivastava, Sanjay Singhal, MLB Bhatt.Problems associated with inadequate surgery in patients with cervical cancer: Can they be avoided?Cancer Research, Statistics and Treatment 5 (1): 145-147; 2022.

PROF. Seema Gupta

1. Arunima Ghosh, Seema Gupta, Danial Johny, Vivek Vidyadhar Bhosale, Mahendra Pal Singh Negi. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers. Cancer Med. 2021;10(15):5175-5190.
2. Seema Nayak, Madan Lal Brahma Bhatt, Madhu Mati Goel, Seema Gupta, Divya Mehrotra, Abbas Ali Mahdi, Anupam Mishra. Aberrant Expression of PTPN-14 and Wilms’ Tumor 1 as Putative Biomarker for Locoregional Recurrence in Oral Squamous Cell Carcinoma. Asian Journal of Oncology. 2021 Vol. 00(1-13)
3. Anjali Sachan, Seema Gupta, Arunima Ghosh, Navin Singh.Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures.J Biomed Phys Eng. 2021;11(3):403–406.
4. D Chakrabarti, S Rajan, N Akhtar, S Qayoom, S Gupta, M Verma, K Srivastava, V Kumar, M L B Bhatt, R Gupta. Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial. Br J Surg. 2021;16;znab020
5. Sachan A, Gupta S, Singh N. Correlation of 3DCRT and Open Field Treatment Techniques in Advanced Head and Neck Cancer Patients Treated by Chemoradiation. J Biomed Phys Eng. 2021;1-8.
6. S Nayak, MLB Bhatt, MM Goel, S Gupta, AA Mahdi, A Mishra, D Mehrotra. Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy. Plos one. 2018(6), e0199665.
7. Seema Gupta, Vandana Kushwaha, Sandeep Verma, Huma Khan, M.L.B. Bhatt, Nuzhat Husain, Mahendra Negi, Vivek Bhosale, AshimGhatak. Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.Heliyon. 2016;2(12),e00206.
8. S Roopali, S. Singh, S. Gupta, M.L.B. Bhatt M. Jain, M. Saha, V. P. Raturi, J. Gaur, D. Kishan, R. Singh. A Prospective Study Comparing Oxaliplatin & 5-Fu with Gemcitabine & Cisplatin in Advanced Stage Carcinoma Gall Bladder. JMSCR. 2016;4(5),10386-10391.
9. Seema Gupta, Rahul Singh, K. Pranay, Kiran P. Malhotra.Secretory Breast Carcinoma in Adult Female: A Case Report and Review of the Literature. IJSR. 2016;5(2):2277-8179.
10. Gupta S, Khan H, Kushwaha VS, Husain N, Negi M, Ghatak A, Bhatt ML. Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation.Cancer BiolTher. 2015;16(9):1269-8.
11. Khan H, Gupta S, Husain N, Misra S, Negi M, Jamal N, Ghatak A. Correlation between expression of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. Elsevier’s Biochimica et Biophysica Acta (BBA) Clinical. 2015; 3, 11–17.
12. Madhup Rastogi, Sharad Singh, Sudhir Singh, Seema Gupta, Raghav C Dwivedi. Triple primary malignant neoplasms including breast, esophagus and base tongue in an elderly male: A case report. J Can Res Ther. 2014; 10:1109-11.
13. Kushwaha VS, Gupta S, Husain N, Khan H, Negi M, Jamal N, Ghatak A. Gefitinib, Methotrexate and Methotrexate plus 5-Florouracil as palliative treatment in recurrent head and neck squamous cell carcinoma.Cancer BiolTher. 2015; 16(2):346-51.
14. Khan H, Gupta S, Husain N, Misra S, Singh N, Negi M. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. J Cancer Res Ther. 2014; 10(2):258-64.
15. Seema Gupta, M.C. Pant, N. Husain, S. Sundar, H. Khan. Primary amelanotic melanoma of nasal cavity: A case report. Ear Nose Throat J. 2014; 93(1):E12-14.
16. Agnes YY Lee, Rupert Bauersachs, Mette S Janas, Mikala F Jarner, Pieter W Kamphuisen, Guy Meyer, Alok A Khorana, on behalf of the CATCH Investigators. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer. 2013; 13:284.
17. Gupta S, Khan H, Barik S, Negi MP.Clinical benefits of concurrent capecitabine and cisplatin versus concurrent cisplatin and 5-FU in locally advanced squamous cell head and neck cancer. Drug DiscovTher. 2013; 7(1):36-42.
18. Seema Gupta,Huma Khan, Sandip Barik, M.P.S. Negi.Efficacy of concurrent chemoradiotherapy with capecitabine and cisplatin in the management of locally advanced squamous cell carcinoma of head and neck. (Abstract).Eur J Cancer Suppl. 2013;49(1):S2
19. Sandip Barik, Vandana Kumari, Naseem Jamal, M. C. Pant, D. Parmar, Sunil Kumar, M.L.B. Bhatt, Rajeev Gupta, Seema Gupta, Kirti Srivastava, Sudhir Singh, Rajendra Kumar, Jitendra Verma, Ankur Dhawan. Association of Polymorphisms in TPMT in Head and Neck Cancer and treatment response to Chemoradiotherapy.J Cancer Res Ther. 2012; 3(8):S186.
20. Vandana Kumari, Sandip Kumar Barik, Sunil Kumar, Naseem Jamal, M. C. Pant, Kirti Srivastava, Sudhir Singh, Yashodhara Pradeep, M.L.B. Bhatt, P. K. Srivastava, Seema Gupta,Rajeev Gupta, Rajendra Kumar, Jitendra Verma. A prospective study to compare concurrent chemoradiation with accelerated radiotherapy alone in locally advanced carcinoma cervix (IIB-IIIB).J Cancer Res Ther. 2012; 3(8):S187.
21. Seema Gupta, H. Khan, N. Husain, S. Mishra. Clinicopathological correlation of Cyclin-D1 expression with chemoradiation response in oral squamous cell carcinoma. (Abstract). Surgery Curr Res. 2012; 2:5.
22. Seema Gupta,Nuzhat Husain,Vandana Kumari_, Sandip Kumar Barik.Soft tissue neuroendocrine carcinoma of Thigh: A case report with literature review. Case Reports in Clinical Medicine. 2012; 1, 9-12.
23. Seema Gupta, Nuzhat Husain, A. Kumar, Sham Sundar. Adult primary pleomorphic leiomyosarcoma of forearm with axillary lymph node metastasis: a case report and literature review: J Cancer Res Ther. 2012; 8(3):448-50.
24. Seema Gupta, Nuzhat Husain, Sham Sundar, A. Shah, Chitiz Srivastava. Adjuvant treatment of unresectable choroid plexus carcinoma with literature review. Journal of Radiosurgery and SBRT (Stereotactic body Radiation Therapy). 2012; 1(4).
25. Seema Gupta, M.C. Pant, N. Husain, S. Sundar, P. K. Singh. Primary Intraparenchymal Brain Melanoma: A Case Report. Journal of Radiosurgery & SBRT (Stereotactic body Radiation Therapy). 2012; 1(4).
26. Seema Gupta, Husain N, Sundar S. Hemorrhagic Brain Metastasis of an amelanotic melanoma Foot: A Case Report. J Cell Sci Ther. 2011, 2:4.
27. Seema Gupta, Husain N, Sundar S. Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: Case report. World J Surg Oncol. 2011; 9:118.
28. Singh PK, Srivastava A, Singh P, Singh D, Dalela D, Goel M, SeemaGupta, Negi MPS, Bhatt M, Rath S. Clinical utility of surviving gene expression in patients with transitional-cell carcinoma of the urinary bladder. Eur J Cancer Suppl. 2011; 9(1):14-15.
29. P. Singh, A Srivatava, P. Singh D. Singh, S. Rath, D. Dalela, M. Goel, Seema Gupta, M. Negi, M. Bhatt. Diagnostic and prognostic potential of CK20 gene expression in patients with transitional-cell carcinoma of the urinary bladder. Eur J Cancer Suppl. 2011; 9(1):4-5.
30. Seema Gupta, M.C. Pant, N. Husain, S. Sundar.Metastatic Medulloblastoma at Diagnosis: A Case Report. J Cancer Res Ther. 2011; 7(2):203-4.
31. Seema Gupta, M.C. Pant, J. K. Verma, S. Sundar, S. Singh. Acute arterial thrombosis related to cisplatin and 5-fluorouracil in patient of carcinoma larynx: a case report. Ear Nose and Throat journal. 2011.
32. Seema Gupta, Singh P.K., Bhatt M.L., Pant M.C., Sundar S.,Verma J., Negi M. P. S. Clinical benefits of Epoetin beta in patients with advanced stage hormone refractory prostate cancer.EurUrol Suppl.2011; 10(2):337.
33. Seema Gupta, Singh P., Khan H., Bhatt M., Pant M.C., Sundar S., Verma J., Negi M. Positive response to bevacizumab with selective bladder conservation in recurrent and metastatic bladder cancer. EurUrol Suppl. 2011; 10(2):211.
34. Srivastava A.K., Singh P.K., Singh P., Singh D., Bhatt M.L.B., Dalela D., Goel M.M., SeemaGupta, Negi M.P.S., Rath S.K. Clinical experience with UCA1 as a biomarker for non-muscular invasive bladder cancer.EurUrol Suppl 2011; 10(2):74.
35. Seema Gupta, Singh PK, Bhatt ML, Pant MC, Sundar S, Verma J, Paul S, Kumar D, Shah A, Gupta R, Negi MPS. Clinical benefits of two different dosing schedules of recombinant human erythropoietin in anemic patients with advanced head and neck cancer. BioScience Trends. 2010; 4(5):267-272.
36. Seema Gupta, Singh PK, Bhatt ML, Pant MC, Sundar S, Verma J, Paul S, Kumar D, Shah A, Gupta R, Negi MPS. Efficacy of Granulocyte Colony Stimulating Factor (G-CSF) as a secondary prophylaxis along with Full-Dose Chemotherapy Following a Prior Cycle of Febrile Neutropenia. BioScience Trends. 2010; 4(5):273-278.
37. Huma Khan, Nuzhat Husain, Seema Gupta, Vandana Tiwari, Hari Ram. Is cyclin-d1 a predictor of response in oral squamous cell carcinoma.Indian journal of Pathology & Microbiology. 2010; 53(1).
38. Milijain, Seema Gupta, NuzhatHusain.Solitary intraparenchymal malignant melanoma of brain: A case report. Indian journal of Pathology and microbiology. 2010; 53(1).
39. Seema Gupta, Singh PK, Bisth SS, Bhatt ML, Pant M, Gupta R, Singh S, Negi MP.Role of recombinant human erythropoietin in patients of advanced cervical cancer treated “by chemoradiotherapy”.Cancer BiolTher. 2009; 8(1):13-7.
40. Gupta D, Shukla P, Bisht SS, Aggarwal A, Dhawan A, Pant MC, Bhatt ML, Gupta R, Srivastava K, SeemaGupta, Srivastava M. Comparitive study of efficacy, tolerability of four field box technique vs. two field anterior posterior technique in locally advanced carcinoma cervix. Cancer BiolTher. 2009; 8(9):759-64.
41. Gupta D, Shukla P, Bisht SS, Dhawan A, Pant MC, Bhatt ML, Seema Gupta, Gupta R, Negi MP. A prospective comparision of sequential chemoradiation vs. concurrent chemoradiation in locally advanced oropharyngeal carcinomas. Cancer BiolTher. 2009; 8(3):213-7.
42. Goyal M, Shukla P, Gupta D, Bisht SS, Dhawan A,SeemaGupta, Pant MC, Verma NS. Oral mucositis in morning vs. evening irradiated patients: A randomised prospective study. Int J Radiat Biol. 2009; 85(6):504-509.
43. M. L. Bhatt, A. Matin, M. Srivastava, M.C. Pant, K. Srivastava, Seema Gupta, M. Rastogi, U. Singh, D. Chhavi. Evaluation of Gemcitabine Versus Cisplatinum as an adjunct to radiotherapy in locally advanced carcinoma uterine cervix. Journal of Clinical Oncology, 2007 ASCO; (25): 18S:16012.
44. P. Shukla, D. Gupta, P. Gupta, S. Singh Bisht, M. C. Pant, Seema Gupta, N. Husain & V. Joshi. Myxofibrosarcoma of Right Fronto-Temporal Region with Intracranial Extension: A case report. The Internet Journal of Oncology.2009 Volume 6.
45. M. C. Pant, S.S. Bisht, R. Pant, M.L. Bhatt and Seema Gupta, M. Rastogi and P.P. shah. Cancer Prevention and tobacco control: role of school education in a rural community. UICC world Cancer Congress Proceeding of the Free Papers Washington, D. C USA, July 8-12, 2006 Medimond International Proceedings.
46. M. C. Pant,P. P. Shah, A. P. Singh, M. Singh, M. L. Bhatt, Rajeev Pant, Seema Gupta, S. S. Bisht, M. Rastogi and D. Parmar. Association of Functionally Important Polymorphisms of Tobacco Responsive Cytochrome P450 and Glutahiome-S-Tranferases with Head & Neck Cancer. UICC world Cancer Congress Proceeding of the Free Papers Washington, D. C USA, July 8-12, 2006 Medimond International.
47. Madanlal. B. Bhatt, M. Srivastava, Sharad Singh, M.C Pant, Gulshan Rai,Seema Gupta, Kirti Srivastava, Diwakar Dalela. Synchronous chemo-radiotherapy for Muscle Invasive Urinary Bladder Carcinoma as an approach to organ conservation. UICC World Cancer Congress Washington, D.C. USA July 8-12, 2006.
48. Seema Gupta, M. C. Pant, Sharad Singh, Shyam Bisht, Rajeev Gupta. Optimization of chemotherapy and Radiotherapy in locally advanced non-small cell Broncogenic carcinoma. Indian Journal of Bio Research (Oncology Volume). 2005; 58(1):7-19.
49. Seema Gupta, M. C. Pant, Sharad Singh, Shyam Bisht and Rajeev Gupta. Innovative Treatment Strategies in small cell lung cancer. Indian Journal of Bio Research (Oncology Volume). 2005; 58(1):47-51.
50. Seema Gupta, M.C. Pant, M.S. Agarwal, M. Srivastava. Role of Altered Fractionation in Cancer Cervix. Indian Journal of Bio Research. 2003; (1):130-143.
51. B. Singh, M.C. Pant, G. Rai, Seema Gupta. Palliation of Painful Bone Metastasis: Effect of 8Gy in single fraction compared to multifractional Radiotherapy. Indian Journal of Bio Research. 2003; 50:18-32.
52. K. K. Singh, Rajeev Srivastava, M. C. Pant, Shyam Singh Bisht, and Seema Gupta. Metastatic Adenocortical Carcinoma A Case Report. Indian Journal of Bio Research. 2003; 50 (7): 35-39.
53. K. K. Singh, Rajeev Srivastava, M.C. Pant, Shyam Singh Bisht and Seema Gupta. Brief Review of Skin tumors. Indian Journal of Bio Research. 2003; 50(7):85-92.
54. K. K. Singh, Rajeev Srivastava, M.C. Pant, Shyam Singh Bisht and Seema Gupta. Nanotechnology: Novel Technology of Near Future. Indian Journal of Bio Research. 2003; 50(7):116-120.
55. Pragya Shukla, Deepak Gupta, Shyam Singh Bisht, Mohan Chand Pant, Madan Lal Bhatt, Rajeev Gupta, Kirti Srivastava, Seema Gupta, Ankur Dhawan, Deepti Mishra, Mahendra Pal Singh Negi. Circadian Variation in Radiation-Induced Intestinal Mucositis in Patients with Cervical Carcinoma. Cancer. 2010; 2031-2035.

Book Chpater

1. Gupta, S. , Srivastava, S. , Singh, N. , Ghosh, A. . Volumetric and Dosimetric Inconstancy of Parotid Glands and Tumor in Head and Neck Cancer during IMRT. In: Badruddeen, B. , Ahmad, U. , Siddiqui, M. A. , Akhtar, J. , editors. Radiation Oncology [Internet]. London: IntechOpen; 2022 [cited 2022 Nov 03]. Available from: https://www.intechopen.com/chapters/82090 doi: 10.5772/intechopen.104745

PROF. Rajendra Kumar

1. A Study on Demographic,Epidemiological and Clinical Evaluaion of Locally Advance and or metastatic Cancer patients registered under Palliative Care Unit in a tertiary hospital in Uttar Pradesh. International Journal of Innovation Scientific Research and Review Vol. 03, Issue, 01, pp.803-807, January, 2021 Geeta Singh, Rashmi Gupta, Rajendra Kumar
2. Population with emphasis to its emerging risk tin the rural retreatJournal of Engineering Technologies and InnovativeResearch:Vol.5, Issue9, September 2018Kumar Rajendra, Singh Aparna, Singh Alankrita, Singh Geeta, Bhatt M.L.B.
3. A prospective randomized comparison of conc-urrent chemo radiationwith neo-adjuvant and Adjuvant chemotherapy with concurrent chemo-radiation alone for locally advanced carcinoma cervix.Indian Journal of medical and PaediatricOncology:Vol.XX, IssueXX, June2018Singh Rahul MD, Bhatt M.L.B. MD, Kumar Rajendra MD, Srivastava Kirti MD,Grover RK MD, Shukla Pragya MD, Ratauri P Vijay MD, Roopali MD, Gaur JalajMD, Saha Mandira MD, KishanDewesh MD.
4. Expression of Radioresistant gene PEG 10 in OSCC patients and its PrognosticSignificance.Asia Pacific Journal of Cancer Prevention,Vol. 18, 1513-1518, June 2017Shankar Sharan Singh; Rajendra Kumar; Vandana Singh Kushwaha; M Lal BrahmBhatt ;Anshuman Singh; Anupam Mishra ; Hari Ram ; Devendra Parmar ; Rajiv Gupta.
5. Role of Matrix metalloproteinase 13 gene expression in the evaluation of radiationresponse in Oral Squamous cell Carcinoma.Journal of Carcinogenesis, Vol.XX, IssueXX April2017Shankar Sharan Singh ; M Lal Brahm Bhatt; Vandana Singh Kushwaha; AnshumanSingh; Rajendra Kumar; Devendra Parmar.
6. Expression Levels of Tetraspanin KA11/CD82 in breast cancer in North IndianFemales. Asia- Pacific Journalof Cancer Prevention Vol 17/2016 Pg No-1-6Richa Singh 1 , Madan Lal Brahma Bhatt 1* Saurabh Pratap Singh, Vijay Kumar, Madhu MatiGoel, Durga Prasad Mishra 6 ,Kirti Srivastava 1 , Rajendra Kumar 1 ,
7. Evolution of KiSS1 as a prognostic biomarker in North Indian Breast Cancer CasesAsia pacific Journal of Cancer PreventionVol. 17, 2016 Pg. no.-1789-1795Richa Singh 1 , Saurabh Pratap Singh 2 , Sanjeev Misra 3 , Vijay Kumar 4 , Madhu MatiGoel 5 , Durga Prasad Mishra 6 , Rajendra Kumar 1 , Madan Lal Brahma Bhatt 1*
8. Altered Transcriptional and Translational Levels of Nm23H1 in North Indian BreastCancer females and it’s Prognostic relevance. International Journal Of Current ResearchVol. 8, Issue 07, July, 2016, Pg. 34081-34086Richa Singh 1 , Madan Lal Brahma Bhatt 1* Saurabh Pratap Singh, Vijay Kumar, Madhu MatiGoel, Durga Prasad Mishra 6 , Rajendra Kumar 1 .
9. Clinico-epidemiological study of oral squamous cell carcinoma : A tertiarycare centre study in North India.Journal Of Oral Biology and Craniofacial Research Vol 6, Issue 1, Jan – Apr 2016, Pg 32-35Mahendra Pratap Singh, Vijay Kumar, Akesh Agarwal, Rajendra Kumar, M.L.B.Bhatt, Sanjeev Mishra
10. Association of Genetic polymorphism of X-Ray repair cross complementing 1 genein locally advanced laryngeal cancer and with treatment response to chemo-radiation
11. International Journal of Science and Research (IJSR) Acceptance Vol.5, Issue 3, March 2016Dr.Ratori Vijay Pashuram , Dr. Rajendra Kumar, Prof. MLB Bhatt, Dr. Parmar, Dr.Singh, Dr. Rahul Singh,Dr.Jalaj Gaur
12. Expression Of Epidermal Growth Factor Receptor (EGFR) And ItsCorrelation With Response In Locally Advanced Carcinoma OfUterine Cervix Treated With Chemo-radiation. International Journal ofScience and Research (IJSR-2017)(Accepted)Pranay Katepogu ; Rajendra Kumar ;Kirti Srivastava ;M.L.B.Bhatt;Sudhir Singh.
13. “SU-GG-T-154: Use of I’mRT matrix X for routine dynamic MLC- QA and IMRT doseverification”.Journal- Medical Physics, June 2008, vol 35 issue 6. P2761Anup Bhardwaj, SC Sharma, FD Patel, S Ghoshal, AS Oinam, R Kapoor,Rajendra Kumar Goswami.P.
14. “Prospective evaluation of High-dose intermittent synchronous cisplatin withRadiotherapy versus Radiation alone in advanced Head and Neck cancer”.Journal of clinical Radiotherapy and oncology Vol.1, No. 1-2: 19-24, March/June 2001.Rajendra Kumar. M.D. ,Jyoti Narain Dwivedi, MD, DMRT, Kamal Sahni, DMRT,MD, A.K. Dixit ,MD, DRM, S.A. Siddiqui , MD, M.L.B. Bhatt.

PROF. Sudhir Singh

1. Hasan F , Katiyar T , Maurya SS , Yadav V , Yadav S , Pandey R , Mehrotra D , Hadi R , Singh S , Bhatt ML , Parmar D , Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients. Biomarkers. 2019 Jun; 4:1-10. doi: 10.1080/1354750X.2019.1609090. (PubMed)
2. Hasan F, Yadav V, Katiyar T, Yadav S, Pandey R, Mehrotra D, Hadi R, Singh S,Bhatt MLB, Parmar D Validation of gene expression profiles of candidate genesusing low density array in peripheral blood of tobacco consuming head and neckcancer patients and auto /taxi drivers with preneoplastic lesions Genomics 2019 Apr2; pii: S0888-7543(18)30632-3. (PubMed)
3. Gupta R, Anand A, Kumar M, Bhatt MLB, Singh S, Sonkar A A Safety and Efficacyof Low-Dose single-agent capecitabine in inoperable gallbladder cancer with jaundicepost-single-system single- catheter external biliary drainage: a pilot study from ahighly endemic area. Indian J Surg Oncol. 2018 Dec; 9(4): 530-537 (PubMed)
4. Ramakant P , Singh KR , Jaiswal S , Singh S , Ranjan P , Rana C , Jain V , Mishra AK ASurvey on Breast Cancer Awareness Among Medical, Paramedical, and GeneralPopulation in North India Using Self-Designed Questionnaire: a Prospective Study.Indian J Surg Oncol. 2018 Sep 5; 9(3): 323-327 (PubMed)
5. Kumar S, Singh S, Dubey A, Srivastava K, Singh A, Gupta R Association ofcytochrome CYP2C9 gene polymorphism in carcinoma of oropharynx andhypopharynx Int J Sci Res, 2018 Feb; 7(2): 42-44 (Index Copernicus)
6. Kumar S, Singh S, Dubey A, Srivastava K, Tiwari D, Gupta R Effect of DrugMetabolising Enzyme Cytochrome CYP2C9 Gene Polymorphism on TreatmentResponse in Carcinoma of Oropharynx and Hypopharynx. Indian J App Sci 2018Feb; 8(2) 7-9(Index Copernicus)
7. Anand A, Singh S, Sonkar AA, Husain N, Singh KR, Singh S, Kushwaha JKExpression of vitamin D receptor and vitamin D status in patients with oral neoplasmsand effect of vitamin D supplementation on quality of life in advanced cancertreatment. Contemp Oncol (Po3n) 2017; 21 (3): 1-7 (PubMed)
8. Katiyar T, Maurya S, Hasan F, Singh A.P., Khan AJ, Hadi R, Singh S, Bhatt MLB,and Parmar D* Association of Cytochrome P450 1B1Haplotypes With Head andNeck Cancer Risk Environmental and Molecular Mutagenesis 00:00^00 (2017)(PubMed)
9. Yadav SK, Singh S, Gupta S, Bhatt MLB, Mishra DP, Roy D, Sanyal S Modulation ofrisk of squamous cell carcinoma head and neck in North Indian population withpolymorphisms in xeroderma pigmentosum complementation Group C, gene. J CanRes Ther 2018 Sep 29; 14(3): 651-7 (PubMed)
10. Barik S, Singh S, Gupta S, Jamal N, Parmar D, Dhawan A, Bhatt MLB Association ofpolymorphism of Enzyme Thiopurine Methyl Transferase in Head & Neck SquamousCell Cancer and treatment response to Concurrent Chemo Radiotherapy. JMSCR2017 Apr; 5(4): 20832-20841 (Index Copernicus)
11. Singh AK, Kushwaha JK, Anand A, Kumar AA, Husain, Srivastava K, Singh S,Human papilloma virus in oral cavity cancer and relation to change in quality of lifefollowing treatment –a pilot study from northern India Indian. J Surg Oncol 2016 Dec;7 (4):386-391 (PubMed)
12. Roopali , Singh S, Gupta S, Bhatt MLB, Jain M, Saha M, Raturi VP, Gaur J, DKishan, Singh S A Prospective Study Comparing Oxaliplatin & 5-Fu withGemcitabine& Cisplatin in Advanced Stage Carcinoma Gall Bladder. JMSCR 2016 May; 4(5)10386-10391 (Index Copernicus)
13. Feza Hasan, TridivKatiyar, Shailendra S. Maurya, Vinay Yadav, Sanjay Yadav, Rahul Pandey, Divya Mehrotra, Rahat Hadi, Sudhir Singh, Madan L. Bhatt & Devendra Parmar Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients Biomarkers, DOI: 10.1080/1354750X.2019.1609090
14. FezaHasana,b, Vinay Yadava, TridivKatiyara,b, Sanjay Yadava,1, Rahul Pandeyc,DivyaMehrotrac, Rahat Hadid, Sudhir Singhc, Madan L.B. Bhattc, Devendra Parmara,⁎ Validation of gene expression profiles of candidate genes using low density array in peripheral blood of tobacco consuming head and neck cancer patients and auto/taxi drivers with preneoplastic lesions Genomics, https://doi.org/10.1016/j.ygeno.2019.04.003
15. Garima Avasthi 1, Amresh Gupta1, TridivKatiyar 2, Vinay Yadav 2, Devendra Parmar 2 Pawan Kadwe 3, Sudhir Singh 4, Madhup Rastogi 5 Gene Polymorphism in Genomic Stability Pathway: A Genetic Driver behind the Emergence of Head and Neck Cancer INTERNATIONAL JOURNAL OF PROGRESSIVE RESEARCH IN SCIENCE AND ENGINEERING, VOL.3, NO.04, APRIL 2022.
16. Shashyendra Singh Gautam a,b,c, Raghwendra Pratap Singh b,d, Kajal Karsauliya a, Ashish Kumar Sonkera,b, Panga Jaipal Reddy e, Divya Mehrotra f, Sameer Gupta g, Sudhir Singh h, Rashmi Kumar b,d,*, Sheelendra Pratap Singh a,b,** Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma Journal of Proteomics doi.org/10.1016/j.jprot.2022.104541
17. Abhay Singh, Sudhir Singh, Mohammad Ali, Deepa Aggarwal, Kirti Srivastava, Madan Lal Brahma Bhatt, Madhup Rastogi1 Association of genetic polymorphism of cytochrome P450 2C9*2 and glutathione S transferase P1 with treatment outcome in patients of locally advanced inoperable head‑and‑neck squamous cell carcinomas treated with concurrent chemoradiotherapy 2021 National Journal of Maxillofacial Surgery DOI 10.4103/njms.njms_300_21
18. Deepa Aggarwal, Sudhir Singh, Mohammad Ali, Abhay Singh, Kirti Srivastava, Rajeev Gupta, Madan Lal Brahma Bhatt Treatment outcomes in poor metabolizers of cytochrome P450 2A6 with concurrent chemoradiotherapy in locally advanced head‑ and neck‑squamous cell carcinoma 2021 National Journal of Maxillofacial Surgery DOI: 10.4103/njms.NJMS_312_2
19. Tridiv Katiyar1,2 | Vinay Yadav1 | Shailendra S. Maurya3 | Munindra Ruwali4 | Madhu Singh5 | Feza Hasan1,2 | Rahul Pandey6 | Divya Mehrotra6 | Sudhir Singh6 | Shambhavi Mishra7 | Rahat Hadi8 | Madan L. B. Bhatt6 | Devendra Parmar1 Interaction of glutathione-s-transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome Environ Mol Mutagen. 2020;61:574–584
20. Vinay Kumar Yadav1,2 | Tridiv Katiyar1 | Munindra Ruwali3 | Sanjay Yadav4 | Sudhir Singh5 | Rahat Hadi6 | Madan Lal Brahma Bhatt5 | Devendra Parmar1,2 Polymorphism in cytochrome P4502A6 reduces the risk to head and neck cancer and modifies the treatment outcome Environ Mol Mutagen. 2021;1–10.
21. Mohammad Ali, Sudhir Singh, Pragya Verma, Geeta Singh, Abhishek Anand, Rajeev Gupta, Kirti Srivastava, Madan Lal Brahma Bhatt. Comparison of the seventh and eighth editions of the AJCC staging systems in oral cancer patients 2022 National Journal of Maxillofacial Surgery DOI: 10.4103/njms.NJMS_488_21

Dr.Navin Singh

1. Srivastava S, Singh N, Kashyap VK. Dosimetric Evaluation of Different Optimization Algorithms Used in Interstitial Brachytherapy of Cervical Carcinoma . J Biomed Phys Eng2021 (Accepted).
2. Sachan A, Gupta S, Singh N. Correlation of 3DCRT and Open Field Treatment Techniques in Advanced Head and NeckCancer Patients Treated by Chemoradiation. J Biomed Phys Eng2021(Accepted).
3. Chaurasia A, Alam SI, Singh N. Oral cancer diagnostics: An overview. Natl J
4. MaxillofacSurg2021;12:324-32. (Review Article)
5. Sachan A, Gupta S, Ghosh A, Singh N. Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures. J Biomed Phys Eng2021;11(3):403-406.(Short Communication)
6. Singh N, Ahamed S, Sinha A, Srivastava S, Painuly NK, Mandal A, Prasad SN. Rectal and bladder dose measurements in the intracavitary applications of cervical cancer treatment with HDR afterloading system: Comparison of TPS data with MOSFET detector. J Biomed Phys Eng2020;10(2):141-146.
7. Goyal H, Singh N,Gurjar OP, Tanwar RK. Radiation induced demyelination in cervical spinal cord of the head-and-neck cancer patients after receiving radiotherapy. J Biomed Phys Eng2020;10(1):1-6.
8. Srivastava S, Painuly NK, Mishra SP, Srivastava K, Singh N, Bhatt MLB. Effect of different definitions of prescription point “A” in high dose rate (HDR) brachytherapy for cervical cancer. J Cancer Res Ther. 2019;15(6):1365-1369.
9. Srivastava S, Painuly NK, Mishra SP, Srivastava K, Singh N, Singh S, Bhatt MLB.
10. Evaluation of volumetric doses of organs at risk in carcinoma cervix patients with HDR
11. intracavitary brachytherapy and comparison of CT-based and conventional plans. J Biomed Phys Eng. 2019;9(6):603-612
12. Sinha A, Singh N, Dixit BM, Painuly NK, Patni HK, Yadav A. Evaluation of Electron Specific Absorbed Fractions in organs of Digimouse Voxel Phantom using Monte Carlo Simulation code FLUKA. J Biomed Phys Eng2019; 9(2):161-166.
13. Singh N, Sharma SD, Painuly NK, Mandal A, Agarwal LM, Sinha A. Underdosing of the Maxillary Sinus for Small Fields used in Newer Radiotherapy Techniques: Comparison of TLD and Monte Carlo Data. J Cancer Res Ther. 2018; 14(2):351-356.
14. Sinha A, Singh N, Dixit BM, Painuly NK. Assessment of S Values for I 131 and Y 90 based on the Digimouse voxel Phantom. J Cancer Res Ther. 2018; 14(6):1298-1302.
16. Singh N, Painuly NK, Chaudhari LN, Chairmadurai A, Verma TR, Shrotiya D, Bhatt CP. Evaluation of AAA and XVMC algorithms for dose calculation in lung equivalent heterogeneity in photon fields: Comparison of calculated results with measurements.J Biomed Phys Eng2018; 8(3):223-30.
17. Ahamed S, Singh N, Gudipudi D, Mulinti S, Kumar A, Soubhagya B, Sresty M. Assessment of monitor unit limiting strategy using volumetric modulated arc therapy for cancer of hypopharynx. Phys Med. 2017;35:73-80.
18. Mandal A, Ram C, Mourya A, Singh N. Small Field Depth Dose Profile of 6MV Photon Beam In A Simple Air-Water Heterogeneity Combination: A Comparison Between AAA Dose Estimation With TLD Dose Measurement. J Cancer Res Ther. 2017;13(3):491-497.
19. Verma TR, Painuly NK, Mishra SP, Singh N, Bhatt MLB, Jamal N, Pant MC. Evaluation of dose calculation accuracy of various algorithms in lung equivalent inhomogeneity: Comparison of calculated data with Gafchromic film measured results. J Cancer Res Ther. 2017; 13(6):1007-1014.
20. Sinha A, Patni HK, Dixit BM, Painuly NK, Singh N. Estimation of Photon Specific
21. Absorbed Fractions in Digimouse Voxel Phantom using Monte Carlo Simulation code FLUKA.J Biomed Phys Eng. 2016; 6(4):209-216.
22. Puzhakkal N, Kochunny AK, Padannayil NM, Singh N,Chalil JE, Umerb JK. Comparison of treatment plans: a retrospective study by the method of radiobiological evaluation. Pol J Med Phys Eng. 2016;22(3):61-68.
23. Verma TR, Painuly NK, Mishra SP, Shajahan M, Singh N, Bhatt MLB, Jamal N, Pant MC. Evaluation of performance of algorithms in Lung IMRT: A comparison of Monte Carlo, Pencil Beam, Superposition, Fast superposition and Convolution algorithms.J Biomed Phys Eng. 2016;6(3):127-138.
24. Gurjar OP, Mishra PK, Singh N,Bagdare P, Mishra SP. Dosimetric study for the
25. development of heterogeneous chest phantom for the purpose of patient specific quality
26. assurance. RadiatProt Environ 2015;38(4): 139-143.
27. Sinha A, Singh N, Gurjar OP, Bagdare P. Acceptance testing and quality assurance of Simulix Evolution radiotherapy simulator. RadiatProt Environ 2015;38(3):102-108.
28. Painuly NK , Singh N , Verma TR , Chairmadurai A , Chaudhari LN , Saily A , Pant MC Evaluation of dose perturbation at the interface of two different density medium using GAFCHROMIC film EBT2 and Monte Carlo code EGSnrc for Co60 beam. J Cancer Res Ther. 2015;11(4):775-9.
29. Khan H, Gupta S, Husain N, Mishra S, Singh N, Negi MPS. Prognostics of Cyclin‑D1 expression with chemo radiation response in patients of locally advanced oral squamous cell carcinoma. J Cancer Res Ther. 2014;10(2): 258-64.

Dr.Teethraj Verma

1. Raoui Yasser, SebihiRajaa, Teerthraj Verma, VP Pandey, Herrassi Yassine, Elghalmi Mohammed et al.
2. Saini A, Verma TR, Pandey VP. Performance evaluation of Monaco radiotherapy treatment planning system using CIRS Thorax Phantom: Dosimetric assessment of flattened and non-flattened photon beams.J Can Res Ther. 2022. Accepted for publication
3. Pandey VP, Verma TR,Tiwari Arnav. Impact of Covid-19 outbreak on radiotherapy of cancer patients: Institutional experiences. Med Phys Int. 2021; 9(2), 211-218
4. Pandey VP, Verma TR. Impact of Covid-19 Outbreak Pandemic on the Radiotherapy Practice: A Survey Study of Indian States. Asian Pacific Journal of Cancer Care. 2021;6 (S1), 35-40.
5. Verma AK, Verma TR, Ratnasekhar CH. Potential Indian Medicinal Plants at The Time of COVID-19 Outbreak. Journal of Medicinal and Aromatic Plant Sciences. 2021; 43(3- 4), 9-14.
6. Verma TR, Painuly N. K, Tyagi M, Johny D, Gupta R, Bhatt M. L. B. Validation of the Gel & Wax Boluses and Comparison of their Dosimetric Performance with Virtual Bolus. J Biomed Phys Eng. 2019;9(6):629-636. https://doi.org/10.31661/jbpe.v0i0.1177.
7. Singh R, Kainth H S, Dev S, Singh G, Mehta D, Verma TR*, et al. Evaluation of positional accuracy of the Varian Exact-arm and R-arm support EPID using IMRT graticule phantom. J Can Res Ther 2019; 15: 204-10.
8. J Biomed Phys Eng. 2019 Feb; 9(1): 17–28.
9. Singh N, Painuly NK, Chaudhari LN, Chairmadurai A, Verma TR, Shrotiya D, et al. Evaluation of AAA and XVMC algorithms for dose calculation in lung equivalent heterogeneity in photon fields: Comparison of calculated results with measurements. J Biomed Phys Eng. 2018 Sep; 8(3): 223–230.
10. Verma TR, Painuly NK, Mishra SP, Singh N, Bhatt MLB, Jamal N, et al. J Cancer Res Ther. Evaluation of dose calculation accuracy of various algorithms in lung equivalent inhomogeneity: Comparison of calculated data with Gafchromic film measured results. J Cancer Res Ther. 2017; 13:1007-14.
11. Verma TR, Painuly NK, Mishra SP, Singh N, Bhatt MLB, et al. Performance evaluation Page 3 of 15
12. Pre-treatment verification of carcinoma breast VMAT plan based on mono-isocentric technique: Assessment of the combined fields feature of new 2D MatriXX arrays resolution. Oncology and Radiotherapy. 2022; 16(8): 16-20Verma TR, Painuly NK, Mishra SP, Yoganathansa SA, Singh N, Bhatt MLB, et al. Evaluation of Lung Density and Its Dosimetric Impact on Lung Cancer Radiotherapy: A Simulation Studyof algorithms in Lung IMRT: A comparison of Monte Carlo, Pencil Beam, Superposition, Fast superposition and Convolution algorithms. J Biomed Phys Eng. 2016; 6(3): 127-8.
13. Yangchen K, Siddharth R, Singh SV, Singh RD, Aggarwal H, Mishra N, et al. A pilot study to evaluate the efficacy of cerrobend shielding stents in preventing adverse radio therapeutic effects in buccal carcinoma patients. J Cancer Res Ther.2016 Jan-Mar; 12 (1):314-7. doi: 10.4103/0973-1482.154015.
14. Shrotriya D, Yadav RS, Srivastava RNL, Verma T R. Design and Development of an Indigenous In-house Tissue-equivalent Female Pelvic Phantom for Radiological Dosimetric Applications. Iran J Med Phys. 2018; 15:200-205. 10.22038/ijmp.2018.26717.1274.
15. Singh R, Verma T R, Kainth H S, Ram C, Mehta D, Rana B S, et al. Evaluation of Positional Accuracy of Epid Using Imrt Graticule Phantom In Extended Source to Imager Distance Setups: Formalism of Qa', International Journal of Current Advanced Research, 2017:6(3), 2389-2393. http://dx.doi.org/10.24327/ijcar.2017. 2393.0015
16. Verma TR, Painuly NK, Mishra SP, Yoganathan SA, Singh N, Bhatt MLB, et al. Dosimetric effect of intra-fractional and inter-fractional target motion in lung cancer radiotherapy techniques. Int J Cancer Ther Oncol. 2015; 3(4):343. DOI: 10.14319/ijcto.34.3
17. Painuly NK, Singh N, Verma TR, Chairmadurai A, Chaudhari LN, Saily A, et al. Evaluation of dose perturbation at the interface of two different density medium using GAFCHROMIC film EBT2 and Monte Carlo code EGSnrc for Co-60 beam. J Cancer Res Ther. 2015; 11:775-9.
18. Singh BP, Vero N, Singh PK, Verma TR. A simplified technique to fabricate tissue bolus device to manage dose distribution in maxillectomy patient with orbital exenteration. J Oral BiolCraniofac Res. 2013; 3(2):102-4.
19. Verma TR, Nirmal K Painuly, MLB Bhatt, Shraddha Srivastava, Navin Singh, Surendra P Mishra, Anoop K Srivastava, Ranjit Singh, Dipak Shrotia. Volume mis-estimation by CT scan: importance of CT performance in precision lung cancer radiotherapy. Journal of Medical Physics. 2017; 42 -63
20. N Singh, NK Painuly, Verma TR, S Srivastava, A Sinha, K Purushothaman, RNL Srivastava. Characteristics comparison between physical wedge and virtual wedge using 6 MV photon beam. Journal of Medical Physics. 2017; 42(1) :185

Book Chapter:

1. Title of Chapter: Effect of Readout Heating Rate and Correction for Temperature Lag, Effective Heating Rate and Thermal Quenching to the Response of TLD-100 (LiF: Mg, Ti)
2. Publisher: Nova Science Publishers, Inc. New York Year: 2021 ISBN: 978-1-68507-138-7
3. Title of Chapter: Radiotherapy in Carcinoma Breast
4. Title of Book - Breast Cancer: Current Treads in Molecular Research Publisher: Bentham Science DoI: 10.2174/9781681089522112010013

Dr. Shraddha Srivastava

1. Srivastava S, Singh N, Singh M N, Varghese M. Determination of variation in dosimetric
2. parameters of treatment planning with Co-60 and Ir-192 sources in high dose rate brachytherapy of cervical
3. carcinoma. Radiat. Phys. Chem. 2021 (Communicated)
4. Srivastava 5, Singh N, Kashyap V K. Optimization methods in interstitial brachytherapy: A
5. comparative study of Inverse Planning Simulated Annealing with Graphical optimization and Geometrical
6. optimization in cervical cancer. J Biomed Phys Eng. 2021 (Accepted)
7. Srivastava S, Painuly NK, Mishra SP, Srivastava K, Singh N, Bhatt MLB. Effect of different
8. definitions of prescription point "A" in high dose rate (HDR) brachytherapy for cervical
9. cancer. J Cancer Res Ther.2019; 15(6):1365-1369.
10. Srivastava S, Painuly NK, Mishra SP, Srivastava K, Singh N, Singh S, Bhatt MLB. Evaluation of volumetric
11. doses of organs at risk in carcinoma cervix patients with HDR intracavitary brachytherapy and comparison of CT-
12. based and conventional plans. J Biomed Phys Eng. 2019; 9(6):603-612.
13. Singh N, Ahamed S, Sinha A, Srivastava S, Painuly NK, Mandal A, Prasad SN. Rectal and
14. bladder dose measurements in the intracavitary applications of cervical cancer treatment
15. with HDR afterloading system: Comparison of TPS data with MOSFET detector. J Biomed Phys
16. Eng. 2020 Apr; 10(2):141-146

Dr. Mrinalini Verma

Publications:

1. Singhal S, Deokar K, Verma M. Commercial Screening tests: beneficial or hypnosis to an advertisement. Journal of Post Graduate Medicine (accepted)
2. Verma M, Singhal S.Hospice care for optimizing the life of patient and caregiver: an unmet need of the hour. Indian Journal of Cancer (accepted)
3. Ali M, Singh S, Verma M, Verma P, Singh G, Anand A, et al. Comparison of the seventh and eighth editions of AJCC staging system in oral cancer patients. Natl J MaxillofacSurg (accepted).
4. Verma M, Singhal S, Deokar K. Is it starting of a New Era in Medicine: Media Influences Practice and Research. Clin Oncol.
5. https://doi.org/10.1016/j.clon.2022.09.048
6. Parikh A, Deokar K, Verma M, Singhal S, Bhatt MLB, Katoch CDS. The 50-year journey of lung cancer screening: a narrative review. Cureus 2022; 14(9):e29381. doi:10.7759/cureus.29381.
7. Verma M, Chakrabarti D, Rajan S, Akhtar N. Real-world cost of systemic therapy for advanced head and neck cancers. IJC
8. https://www.indianjcancer.com/preprintarticle.asp?id=348450
9. Verma M, Kukreja D, Singhal S. Had we touched the finishing line! Urologic Oncology: Seminars & Original Investigations doi.org/10.1016/j.urolonc.2022.07.003
10. Verma M, Srivastava K, Singhal S, Bhatt M L. Problems associated with inadequate surgery in patients with cervical cancer: Can they be avoided? Cancer Res Stat Treat 2022;5:145-7.
11. Prakash S, Chakrabarti D, Kumar R, Agrawal MM, Verma M, Singh S, Gupta S, Srivastava K, Gupta R, Bhatt MLB. Palliative radiotherapy: a one-week course in advanced head and neck cancer - quality of life outcomes. BMJ Support Palliat Care doi: 10.1136/bmjspcare-2021-002908. PMID: 35428653.
12. Chakrabarti D, Verma M, Kukreja D, Bhatt MLB. Targeted Therapies for Head and Neck Cancers in Developing Countries: Where are We Actually at? Clin Oncol (R Coll Radiol) 2022. S0936-6555(22)00085-1. doi: 10.1016/j.clon.2022.02.001. PMID: 35197208.
13. Kukreja D, Chakrabarti D, Verma M. Current Role of Radiation in Thyroid Cancers. Indian Journal of Endocrine Surgery and Research 2021;16:86.
14. Kukreja D, Chakrabarti D, Resu AV, Verma M, Bhatt ML. Atypical herpes zoster reactivation in an elderly gentleman with advanced oral cancer.Bengal J Cancer 2021;1:47-8.
15. Chakrabarti D, Verma M, Kukreja D, Shukla M, Bhatt MLB. Palliative chest wall radiotherapy for a fungating and bleeding metastatic breast cancer: quality of life beyond cure. BMJ Case Rep 2021;14:e243722.
16. Chakrabarti D, Akhtar N, Rajan S, Qayoom S, Kumar V, Chaturvedi A, Verma M, Gupta R, Bhatt MLB, Parveen S. What Is the Acceptable Noninferiority Limit for Nodal Recurrences When Ascertaining Sentinel Lymph Node Biopsy as an Alternative to Neck Dissection for Early Oral and Oropharyngeal Cancers? J Clin Oncol 2021;39:1599-1600.
17. Misra S, Mishra A, Lal P, Srivastava R, Verma M, Senthil Kumar SK, Maria Das KJ. Cardiac dose reduction using deep inspiratory breath-hold (DIBH) in radiation treatment of left-sided breast cancer patients with breast conservation surgery and modified radical mastectomy. J Med Imaging Radiat Sci 2021;52:57-67.
18. Rajan S, Chakrabarti D, Akhtar N, Kumar V, Verma M. Searching for answers: Cancer care during the COVID pandemic.Clin Epidemiol Glob Health 2021;10:100696.
19. Chakrabarti D, Rajan S, Akhtar N, Sumaira Q, Verma M, Srivastava K, Kumar V, Bhatt MLB, Gupta R. Short course radiotherapy with consolidation chemotherapy versus conventionally fractionated long course chemoradiotherapy for the pre-operative management of locally advanced rectal cancers: a randomised open label clinical trial from a developing country. BJS 2021;5: 511-20.
20. Chakrabarti D, Rajan S, Verma M, Akhtar N, Kumar V. Apples and oranges: Comparison of two surgical procedures with different indications for the management of oral squamous cell carcinoma. J Surg Oncol. 2020;1–2.
21. Chakrabarti D, Qayoom S, Kukreja D, Resu AV, Rajan S, Verma M, et al. A middle-aged man with adenoid cystic lung carcinoma: not every dyspnoea is the novel coronavirus, even during a pandemic. Journal of Radiotherapy in Practice. Journal of Radiotherapy in Practise 2020;:1–3.
22. Verma M, Singhal S, Shrivastava P, Prasad R. A complete holistic approach in a patient of advanced lung cancer with severe breathlessness. Clinics Oncol 2020;5:1731.
23. Verma M,Chakrabarti D. Are the classical indications of postoperative chemoradiotherapy in head and neck squamous cell cancers valid in the era of neoadjuvant chemotherapy? Oral Oncol 2020;107:104838.
24. Verma M. Solitary cutaneous metastasis in the palmer aspect of hand, along with pulmonary metastasis – a rare presentation in an early laryngeal primary and review of literature. Oncol J India 2020;4:73-5.
25. Verma M, Lal P, Das KJM, Kumar S.Adaptive intensity modulated Radiotherapy (IMRT) in head and neck cancer (HNC) patients treated by chemo-radiotherapy: to quantify temporal changes during the course of Radiotherapy (RT) and to study the impact of these changes on the baseline treatment plans.J Radiat Cancer Res 2020;11:17-24.
26. Chakrabarti D,Verma M. Low dose radiotherapy for SARS-CoV-2 pneumonia.StrahlentherOnkol 2020;196:736-7.
27. Verma M, Pandey L. Low grade endometrial stromal sarcoma: a case report. International Journal of Current Advanced Research 2020;9:21040-2.
28. Yadav R, Lal P, Agarwal S, Misra S, VermaM, Das KJ, Kumar SKS, Kumar A, Mishra SK, Agarwal A, Agarwal G, Mishra A, Chand G, Verma AK, Kumar S. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center? J Can Res Ther 2020;16:1314-22.
29. Harsvardhan R, Gupta PK, Verma M, Maria Das K J, Lal P, Kumar S. To Assess the Loco-Regional Variation in the Drainage and Referral Pattern at A Regional Cancer Center as A Pre Run before Starting Hospital-based Cancer Registry Program in Northern India. J Indira Gandhi Inst Med Sci 2019;5:69-71.
30. Pandey L, Verma M, Khandelwal R, Nandan S, Kumar P. Primary tubercular mastitis mimicking carcinoma breast-a case report with review of literature. International Journal of Current Advanced Research 2018;7:14887-90.
31. Verma M. Magic word “Palliative”: an end to cure but no end to care. Indian J Palliat Care 2018;24:545-6.
32. Lal P, Nautiyal V, Verma M, Yadav R, Maria Das KJ, Kumar S. Objective and subjective assessment of xerostomia in patients of locally advanced head and neck cancers treated by intensity modulated radiotherapy. J Can Res Ther 2018; 14:1196-201.
33. Verma M, Sait AA, Kumar SKS, Maria Das KJ, Lal P, Kumar S. An audit of setup reproducibility in radiotherapy (RT) of head and neck. J Radiat Cancer Res 2016;7:85-9.
34. Lal P, Verma M, Kumar G, Shrivastava R, Kumar S. Initial experience of head and neck cancer (HNC) patients treated in an Oncologist led Palliative Cancer Care Clinic at a tertiary cancer care center in Uttar Pradesh– is the initiative of a full-fledged palliative care for cancer patients justified. Indian J Palliat care 2016;22:477-84.
35. Lal P, Verma M, Das KJM, Kumar S. IMRT in head and neck cancers: in which direction are we heading? J Radiat Cancer Res 2016;7:37-41.
36. Khurana R, Verma M, Swain PK, Bhatia V, Dabadghav P, Behari S, Banerji D, Kumar S. An audit of over two decades of treating pituitary adenomas at a tertiary care facility. J Radiat Cancer Res 2016;7:117-21.
37. Gupta PK, Lal P, Bajpai R, Goel A, Yadav R, Verma M, Kumar S. Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer. South Asian J Cancer 2016;5:80-4.
38. Verma M, Lal P. Leiomyosarcoma of tongue: a case report and review of literature. Asian J Oncol 2016;2:82-4.
39. Verma M, Kumar P, Lal P, Kumar S. A rare case of low grade myofibroblastic sarcoma of the mandible. International J of Advances in case reports 2015;2:1117-8.
40. Nautiyal V, LalP,Verma M, Yadav R, Singh N,KumarS.Evaluation of fatigue in Head-and-neck cancer patients undergoing(Intensity Modulated Radiation Therapy)Radiotherapy:A prospective study. Asian J Oncol 2015;1:44-8.
41. Verma M, Singhal S. Life threatening lymphoedema in head and neck cancer. J Clin Case Rep 2015;5:510. doi:10.4172/2165-7920.1000510.
42. Verma M, Rungta S. Biomass fuel exposure and lung cancer in females. Acta Biomedica Scientia 2015;2:243-5.
43. Lal P, Nautiyal V, Chaudhuri T, Verma M, Das KJM, Kumar S. Is aspiration as detected on pre-treatment video-fluorography, a harbinger of poor quality of life and early mortality in cancers of the upper aero-digestive tract treated with radiotherapy? South Asian J Cancer 2014; 3: 209-12.
44. Singhal S, Chopra V, Kiran S, Verma M. Life-threatening upper airway obstruction associated with prior radiotherapy. South Asian J Cancer 2013; 2:219.
45. Verma M, Puja K, Kukreja D, Mallick A, Chakrabarti D, Srivastava K, Bhatt MLB. Miniature molecules and the mammoth treatment changes in endometrial cancer. Annals Oncol 2022;33:S1429.
46. Puja K, Verma M, Kukreja D, Bhatt MLB. CROSS protocol for esophageal cancer in India: Reality or pipe dream. Ann Oncol 2022;33:S1112-3.
47. D. Chakrabarti, A. Ghosh, M. Verma, D. Kukreja, N.Akhtar, S. Rajan, S. Qayoom, P. Ramakant, V. Kumar, K Srivastava, R. Gupta, MLB Bhatt. Outcome of male breast cancer patients at an academic university hospital in India (ESTRO 2022).
48. D. Chakrabarti, S. Qayoom, D. Kukreja, M. Verma, K. Srivastava, MLB Bhatt.Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing radiotherapy (ESTRO 2022).Radiotherapy & Oncology 2022.https://doi.org/10.1016/S0167-8140(22)03323-0
49. D. Chakrabarti, M. Verma, S. Qayoom, D. Kukreja, N.Akhtar, S. Rajan, V. Kumar, K Srivastava, R. Gupta, MLB Bhatt. Neoadjuvant chemotherapy may alter extranodal extension in head and neck squamous cell cancers (ICHNO-ECHNO 2022). Radiotherapy & Oncology 2022;168:S77-9.
50. D. Chakrabarti, M. Verma, D. Kukreja, N.Akhtar, S. Rajan, S. Qayoom, V. Kumar, K Srivastava, R. Gupta, MLB Bhatt. Safety data of Phase I/II trial of hypofractionated radiotherapy in resected oral cancers (HYPO-ART) (ICHNO-ECHNO 2022). Radiotherapy & Oncology 2022;168:S69-71.
51. Kukreja D, Diwakar A, Shukla M, Chakrabarti D, Verma M, Bhatt ML. Palliative radiotherapy for fungating lesions in metastatic breast cancers-a single-institution experience. Indian J Cancer 2021;58:S5.
52. Ckakrabarti D, Ghosh A, Kukreja D, Resu AV, Verma M, Bhatt MLB. Audit of male breast cancer patients at a tertiary care academic university hospital in India. Indian J cancer 2021;58:S1.
53. D. Chakrabarti, M. Verma, D. Kukreja, A.V. Resu, K. Srivastava, R. Gupta, M.L.B. Bhatt. The demographics of cancer care in a developing country: ten years experience from an academic university hospital in India. Annal Oncol 2021;32:S1106-7.https://doi.org/10.1016/j.annonc.2021.08.840.
54. Kukreja D, Chakrabarti D, Resu AV, Verma M, Qayoom S, Rajan S, Akhtar N, Gupta R, Bhatt MLB. Impact of induction chemotherapy (ICT) in borderline resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC). Ann Oncol 2021;32:S808.
55. Chakrabarti D, Rajan S, Akhtar N, Qayoom S, Verma M, Gupta R. Dose escalated short-course radiotherapy in rectal cancers: Is this the way forward? Ann Oncol 2020;31:S93.
56. Lal P, Yadav R, Misra S, Verma M, Das KJM, Kumar SKS, Kumar S. An Audit of Hypofractionated Radiotherapy (HFRT) in Breast Cancer Patients Treated at a Tertiary Care Academic Centre: Outcomes and Acute Toxicity. Clinical Oncol 2017;29:e77.
57. Yadav R, Lal P, Agarwal S, Verma M, Misra S, Das KJM, Kumar SKS, Kumar S. Hypofractionated radiotherapy (HFRT) versus conventional radiotherapy: is there a difference in loco-regional recurrence rate when used in unselected breast cancer patient population in tertiary care academic centre? Radiotherapy Oncol 2016;119:S547-8.
58. Gupta PK, Verma M, Yadav R, Lal P. Long term results of comparison of concurrent low dose daily cisplatin versus the standard weekly cisplatin with 6 fractions week radiotherapy in locally advanced head and neck cancer HNC. (Oral presentation at FHNO 2015)
59. Singh S, Verma M, Yadav R, Kumar SK, Maurya AK, Kumar S. Feasibility study of intensity modulated radiotherapy in cancer cervix with inadequate surgical staging: analysis of locoregional control & toxicities. Int J Gynecol cancer 2013;23(S1):269.
60. Lal P, Verma M, Nautiyal V, Raj K, Roy P, Kumar S, Das KJM, Kumar S. Head and neck cancer treated by IMRT with or without chemotherapy-an audit from a single institution. JAMA 2014.
61. Verma M, Sait AA, Kumar SKS, Das KJM, Lal P, Kumar S. “An audit of setup reproducibility in radiotherapy of head and neck cancer”. JAMA 2014.
62. Nautiyal V, Lal P, Verma M, Roy P, Yognathan S, Das KJM, Kumar S. Assessment of Salivary Output and Quality of Life in Patients of Locally-Advanced Head-and-Neck Cancers Treated by Intensity Modulated Radiation Therapy (IMRT). International Journal of Radiation Oncology Biology Physics 2013;87:S608.https://doi.org/10.1016/j.ijrobp.2013.06.1608.
63. Kumar S, Lal P, Das KJM, Rastogi N, Agarwal S, Singh S, Kumar SKS, Sait AA, Gupta PK, Verma M, Yadav R, Chaudhuri T, Narang K. “A process audit of intensity modulated radiotherapy in an academic tertiary care hospital” Indian J of Cancer 2013;Vol. 50(supplement 1): S-301
64. Verma M, Raj DG, Kumar SKS, Das KJM, Lal P, Kumar S. “An audit of setup reproducibility in radiotherapy of head and neck cancers” Indian J of Cancer 2013;Vol. 50(supplement 1): S-162
65. Nautiyal V, Lal P, Verma M, Singh N, Kumar S. “Evaluation of fatigue on head and neck cancer patients undergoing radiotherapy and comparison with age matched controls” Indian J of Cancer 2013;Vol. 50(supplement 1): S-163
66. P. Ramakant, G. Bhat, M Verma, KR Singh, C. Rana, AK Mishra. Randomised Controlled Phase 3 trial on comparing efficacy and safety of neo-adjuvant concurrent chemo-radiation with neoadjuvant chemotherapy alone in patients with locally advanced breast cancer. International Surgical week ISW 2022 on 15-18 August abstract volume.
67. D. Kukreja, M. Verma, D. Chakrabarti, N. Akhtar, R. Gupta, MLB Bhatt. A feasibility study of neoadjuvant chemotherapy (standard TPF regimen) in borderline resectable and unresectable locally advanced oral squamous cell carcinoma (OSCC) (UPAROICON 2021).
68. Kukreja D, Chakrabarti D, Resu AV, Tuteja J, Qayoom S, Verma M. A middle aged man with progressive dyspnoea. (Poster) at NALCCON 2019: 10^th Annual conference of Indian society for study of lung cancer on 14^th and 15^th Dec 2019 at KGMU, Lko
69. Verma SK, Lal P, Verma M, Srivastava R, Agrawal S, Kumar S. An audit of neo-adjuvant chemotherapy administered prior to radiotherapy/chemoradiotherapy in advanced head and neck carcinoma at a tertiary care cancer center. UPAROI 29^th Manual
70. Kumar D, Yadav R, Lal P, Agarwal S, Verma M, Misra S, Das KJM, Kumar SKS, Kumar S. Is there a case for giving internal mammary chain (IMC) irradiation in central/linear quadrant tumors based on a failure patterns observed in a retrospective audit of an unselected breast cancer patient population? UPAROI 29^th Manual
71. Kumar S, Srivastava R, Verma M, Kapoor S, Lal P, Kumar S. Pain palliation with minimum cost: experience from a tertiary cancer care centre in a developing country. UPAROI 29^th Manual
72. Gupta P, Lal P, Verma M, Srivastava R, Das KJM, Kumar S. A retrospective study of oral cavity cancers (OCC): a single institution experience. UPAROI 29^th Manual
73. Harsvardhan R, Gupta PK, Verma M, Das KJM, Lal P, Kumar S. To assess the drainage pattern at a regional cancer centre (RCC) in Northern India. 37^th Annual Scientific Meeting of the International Association of cancer registries, 8-10 October 2015, Taj Mahal Palace, Mumbai India. (Poster)
74. Yadav R , Lal P , Agarwal S, Misra S, Verma M , Kumar S.To study the association between high risk factors and distant failure in an unselected non metastatic breast cancer patient population when treated at in a tertiary care academic centre. Souveneir 27^th UPCON 2016 held at Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow on 19^th -20^th March 2016 (Best Prize)
75. Yadav R, Lal P, Agarwal S, Verma M, Misra S, Das KJM, Kumar SKS, Kumar S. Hypofractionated radiotherapy (HFRT) versus conventional radiotherapy: is there a difference in loco-regional recurrence rate when used in unselected breast cancer patient population in tertiary care academic centre? (Paper presentation at SGPGI breast course 13-14^th Feb 2016). (Best paper award)
76. Yadav R, Lal P, Agarwal S, Verma M, Misra S, Das KJM, Kumar SKS, Kumar S. Hypofractionated radiotherapy (HFRT) versus conventional radiotherapy: is there a difference in loco-regional recurrence rate when used in unselected breast cancer patient population in tertiary care academic centre? (paper presentation at AROICON on 26^th-29^th Nov 2015 at KGMU, Lucknow)
77. Singh N, Habeeb Z, Verma M, Kumar S, Lal P. Assessment of protein, calorie and weight changes in head and neck cancer patients before and after radiation treatment. Poster presentation at 37^th Annual Conference of Association of Radiation Oncologists of India on 26^th-29^th Nov 2015 at KGMU, Lucknow.
78. Verma M, Das KJM, Lal P. IMRT in head and neck cancers in which direction are we heading? Souveneir 37^th annual conference of AROI held at KGMU Lucknow on 26^th-29^th Nov 2015.
79. Kumar G, Verma M, Lal P. End of life care. Souveneir 37^th annual conference of AROI held at KGMU Lucknow on 26^th-29^th Nov 2015.
80. Jain S, Verma M, Yadav R, Das KJM, Kumar S, Lal P. Re-irradiation (Re RT) in Head & neck cancer (HNC)-IMRT versus 3D-CRT, a dosimetric comparison. UPAROI-2014 (26^th UP chapter of Association of Radiation Oncologist of India) at Bareilly on 11^th& 12^th October 2014. (Best Prize)
81. Verma M, Srivastava R, Lal P, Kumar S. Role of cancer directed therapy in head & neck cancer (HNC) patients-an initial audit. UPAROI-2014 (26^th UP chapter of Association of Radiation Oncologist of India) at Bareilly on 11^th& 12^th October 2014.
82. Das KJM, Sait AA, Kumar SKS, Verma M, Lal P, Kumar S. Optimization and evaluation: IMRT of sino-nasal carcinoma in reference to ICRU-83”AAPM 2014.
83. Verma M, Swain PK, Khurana R, Singh S, Bhatia VL, Gupta S, Nisha RS, Dabadghao P, Behari S, banerji D, Jaiswal AK, Das KJM, Kumar S. “Radiotherapy for pituitary adenoma: A single institution audit” 6^th annual conference of Indian society of Neuro-oncology at Department of Radiotherapy, SGPGIMS Lucknow on 11^th-13^th of April 2014.
84. Verma M, Kumar S, Paul U, Das KJM, Lal P, Kumar S. “Quantification of setup errors using portal imaging in head and neck cancers treated with IMRT”. XXIV UP AROICON GKP by association of radiation oncologists of India, at Gorakhpur on 27 Feb 2011. (Best paper awarded)
85. Verma M, Das KJM, Lal P, Kumar S. “Evaluation of adequacy of target coverage and sparing of organs at risk of head and neck cancer patients treated with IMRT” at 32^nd AROICON held at Patna on 25-28 November 2010.

Book Chapter

1. Teerthrajverma, Mranaliniverma, Ratnasekhar Ch; Radiotherapy in Carcinoma Breast, Breast Cancer: current trends in molecular research (2022) 1:219.https://doi.org/10.2174/9781681089522112010013. Bentham Science Publisher